{"content":"<li class=\"n-box-item date-title\" data-end=\"1539662399\" data-start=\"1539576000\" data-txt=\"Monday, December 23, 2019\">Monday, October 15, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3397497\" data-ts=\"1539657608\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTOO\" target=\"_blank\">TTOO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397497-t2-biosystems-files-for-100m-mixed-shelf-offering-shares-down-3-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">T2 Biosystems files for $100M mixed shelf offering; shares down 3% after hours</a></h4><ul><li>T2 Biosystems (NASDAQ:<a href='https://seekingalpha.com/symbol/TTOO' title='T2 Biosystems'>TTOO</a>) has filed a <a href=\"https://www.sec.gov/Archives/edgar/data/1492674/000119312518299340/d637411ds3.htm\" target=\"_blank\">prospectus </a>for a $100M mixed shelf offering. Shares are down&nbsp;<font color='red'>3%</font>&nbsp;after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397497\" data-linked=\"T2 Biosystems files for $100M mixed shelf offering; shares down 3% after hours\" data-tweet=\"$TTOO - T2 Biosystems files for $100M mixed shelf offering; shares down 3% after hours https://seekingalpha.com/news/3397497-t2-biosystems-files-for-100m-mixed-shelf-offering-shares-down-3-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3397497-t2-biosystems-files-for-100m-mixed-shelf-offering-shares-down-3-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:40 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397496\" data-ts=\"1539657480\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RWLK\" target=\"_blank\">RWLK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397496-rewalk-robotics-files-for-equity-offering-shares-down-12-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ReWalk Robotics files for equity offering; shares down 12% after hours</a></h4><ul><li>ReWalk Robotics (NASDAQ:<a href='https://seekingalpha.com/symbol/RWLK' title='ReWalk Robotics'>RWLK</a>) has filed a <a href=\"https://www.sec.gov/Archives/edgar/data/1607962/000121390018013947/fs12018_rewalkrobotics.htm\" target=\"_blank\">preliminary prospectus</a> for a public offering of Units, each consisting of one common share and one warrant to purchase one common share. Prices, volumes and terms have yet to be announced.</li><li>Shares are down&nbsp;<font color='red'>12%</font>&nbsp;after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397496\" data-linked=\"ReWalk Robotics files for equity offering; shares down 12% after hours\" data-tweet=\"$RWLK - ReWalk Robotics files for equity offering; shares down 12% after hours https://seekingalpha.com/news/3397496-rewalk-robotics-files-for-equity-offering-shares-down-12-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3397496-rewalk-robotics-files-for-equity-offering-shares-down-12-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397486\" data-ts=\"1539640130\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PANW\" target=\"_blank\">PANW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397486-palo-alto-networks-names-googles-singh-new-president\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Palo Alto Networks names Google&#39;s Singh as new president</a></h4><ul>     <li>Palo Alto Networks (NYSE:<a href='https://seekingalpha.com/symbol/PANW' title='Palo Alto Networks'>PANW</a>) <font color='red'>-3.8%</font> after-hours as it names Amit Singh as its <a href=\"https://seekingalpha.com/pr/17301061-palo-alto-networks-appoints-amit-k-singh-president\" target=\"_blank\">new president</a>, succeeding Mark Anderson, effective Nov. 1, and reiterates its FQ1 financial outlook.</li>     <li>Singh was the president of Google Cloud and, most recently, Google's VP of business and operations in emerging computing platforms, including augmented and virtual reality; he previously spent 20 years with Oracle in various product, engineering, sales and strategy roles.</li>     <li>PANW also reiterates its Q1 adjusted EPS guidance of $1.04-$1.06 on revenue of $625M-$635M; analyst consensus forecasts EPS&nbsp;of $1.06 on revenue of $632M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397486\" data-linked=\"Palo Alto Networks names Google&#39;s Singh as new president\" data-tweet=\"$PANW - Palo Alto Networks names Google&#39;s Singh as new president https://seekingalpha.com/news/3397486-palo-alto-networks-names-googles-singh-new-president?source=tweet\" data-url=\"https://seekingalpha.com/news/3397486-palo-alto-networks-names-googles-singh-new-president\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397484\" data-ts=\"1539639346\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLSK\" target=\"_blank\">CLSK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397484-after-hours-gainers-losers-10-15-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (10/15/2018)</a></h4><ul><li><b>Top Gainers:</b>&nbsp;<a href='https://seekingalpha.com/symbol/CLSK' title='Cleanspark, Inc.'>OTCQB:CLSK</a>&nbsp;<font color='green'>+45.8%</font>. <a href='https://seekingalpha.com/symbol/SEND' title='SendGrid, Inc.'>SEND</a>&nbsp;<font color='green'>+14.3%</font>. <a href='https://seekingalpha.com/symbol/ADBE' title='Adobe Systems Incorporated'>ADBE</a>&nbsp;<font color='green'>+5.1%</font>. <a href='https://seekingalpha.com/symbol/GFI' title='Gold Fields Limited'>GFI</a>&nbsp;<font color='green'>+4.7%</font>. <a href='https://seekingalpha.com/symbol/TLRY' title='Tilray, Inc.'>TLRY</a>&nbsp;<font color='green'>+1.8%</font>.</li><li><b>Top Losers:</b> <a href='https://seekingalpha.com/symbol/JELD' title='JELD-WEN Holding, Inc.'>JELD</a> <font color='red'>-11.6%</font>. <a href='https://seekingalpha.com/symbol/FTNW' title='FTE Networks, Inc.'>FTNW</a> <font color='red'>-3.3%</font>. <a href='https://seekingalpha.com/symbol/KMPH' title='KemPharm'>KMPH</a>&nbsp;<font color='red'>-1.4%.</font>&nbsp;<a href='https://seekingalpha.com/symbol/CY' title='Cypress Semiconductor Corporation'>CY</a> <font color='red'>-0.8%</font>. <a href='https://seekingalpha.com/symbol/SIRI' title='Sirius XM Holdings Inc.'>SIRI</a> <font color='red'>-0.8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397484\" data-linked=\"After Hours Gainers / Losers (10/15/2018)\" data-tweet=\"$CLSK $CLSK $SEND - After Hours Gainers / Losers (10/15/2018) https://seekingalpha.com/news/3397484-after-hours-gainers-losers-10-15-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3397484-after-hours-gainers-losers-10-15-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397475\" data-ts=\"1539638355\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HQCL\" target=\"_blank\">HQCL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397475-hanwha-q-cellsplus-8_6-on-go-private-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hanwha Q CELLS +8.6% on go-private deal</a></h4><ul><li>        Hanwha Q CELLS (NASDAQ:<a href='https://seekingalpha.com/symbol/HQCL' title='Hanwha Q CELLS Co., Ltd.'>HQCL</a>) <a href=\"https://seekingalpha.com/pr/17301007-hanwha-q-cells-enters-definitive-agreement-going-private-transaction\" target=\"_blank\">agrees to be acquired</a> by Hanwha Solar in an all-cash transaction with an equity value of about $825M.</li><li>               At the time of the merger, each ADS will cease to exist and exchange for $9.90 in cash without interest. &nbsp;&nbsp;&nbsp;</li><li>               The deal value represents a 50% premium to the ADS closing price on August 2, the last trading day prior to Hanwha announcing its interest in acquiring the rest of the HQCL it didn&rsquo;t already own.&nbsp;</li><li>               HQCL shares are&nbsp;<font color='green'>up 8.6%</font>&nbsp;aftermarket to $9.&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3378395-hanwha-q-cells-plus-25-percent-receiving-going-private-proposal-letter\" target=\"_blank\">Hanwha Q CELLS +25% after receiving \"going private\" proposal letter</a> (Aug. 3)</li></ul><div class=\"tiny-share-widget\" data-id=\"3397475\" data-linked=\"Hanwha Q CELLS +8.6% on go-private deal\" data-tweet=\"$HQCL - Hanwha Q CELLS +8.6% on go-private deal https://seekingalpha.com/news/3397475-hanwha-q-cellsplus-8_6-on-go-private-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3397475-hanwha-q-cellsplus-8_6-on-go-private-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:19 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397467\" data-ts=\"1539636998\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWLO\" target=\"_blank\">TWLO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397467-twiliominus-4-on-2b-purchase-of-sendgrid-sendplus-13_6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Twilio -4% on $2B purchase of SendGrid; SEND +13.6%</a></h4><ul><li>Twilio (NYSE:<a href='https://seekingalpha.com/symbol/TWLO' title='Twilio'>TWLO</a>) <a href=\"https://seekingalpha.com/pr/17301045-twilio-acquire-sendgrid-leading-email-api-platform\" target=\"_blank\">will acquire</a> email API platform SendGrid (NYSE:<a href='https://seekingalpha.com/symbol/SEND' title='SendGrid, Inc.'>SEND</a>) in an all-stock transaction valued at about $2B.</li><li>The deal breaks down to approximately $36.92/share. The transaction is expected to close in 1H19.</li><li>SendGrid will continue to exist as a subsidiary and both companies will report earnings on November 6.</li><li>Twilio will have a conference call today at 5:30 ET PM to discuss the purchase with a webcast available <a href=\"https://investors.twilio.com/home/default.aspx\" target=\"_blank\">here</a>.</li><li>Twilio shares are&nbsp;<font color='red'>down 4.1%</font>&nbsp;aftermarket to $73.02.</li><li>SEND shares are<font color='green'> up 13.6%&nbsp;</font>to $35.15.</li><li>Post and title updated to include SendGrid movement.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397467\" data-linked=\"Twilio -4% on $2B purchase of SendGrid; SEND +13.6%\" data-tweet=\"$TWLO $TWLO $SEND - Twilio -4% on $2B purchase of SendGrid; SEND +13.6% https://seekingalpha.com/news/3397467-twiliominus-4-on-2b-purchase-of-sendgrid-sendplus-13_6?source=tweet\" data-url=\"https://seekingalpha.com/news/3397467-twiliominus-4-on-2b-purchase-of-sendgrid-sendplus-13_6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397461\" data-ts=\"1539636223\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JELD\" target=\"_blank\">JELD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397461-jeld-wen-tumbles-11-after-preliminary-results-cfo-departure\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jeld-Wen tumbles 11% after preliminary results, CFO departure</a></h4><ul><li><a href=\"https://seekingalpha.com/pr/17300985-jeld-wen-announces-preliminary-financial-results-third-quarter-fiscal-2018-date-conference\" target=\"_blank\">Noting lower-than-hoped </a>revenue in North America and Europe, along with unfavorable channel mix, Jeld-Wen (NYSE:<a href='https://seekingalpha.com/symbol/JELD' title='JELD-WEN Holding, Inc.'>JELD</a>) sees Q3 adjusted EBITDA of $130M-$135M vs. the previous outlook for $143M-$153M.</li><li>Full-year adjusted EBITDA is now seen at $455M-$470M vs previous outlook of $500M-$520M.</li><li>CFO Brooks Mallard <a href=\"https://seekingalpha.com/pr/17300991-jeld-wen-announces-departure-brooks-mallard-cfo-promotion-john-linker-cfo\" target=\"_blank\">is out</a>, replaced by John Linker.</li><li>Shares&nbsp;<font color='red'>down 11%</font>&nbsp;after hours</li></ul><div class=\"tiny-share-widget\" data-id=\"3397461\" data-linked=\"Jeld-Wen tumbles 11% after preliminary results, CFO departure\" data-tweet=\"$JELD - Jeld-Wen tumbles 11% after preliminary results, CFO departure https://seekingalpha.com/news/3397461-jeld-wen-tumbles-11-after-preliminary-results-cfo-departure?source=tweet\" data-url=\"https://seekingalpha.com/news/3397461-jeld-wen-tumbles-11-after-preliminary-results-cfo-departure\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:43 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397457\" data-ts=\"1539635794\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TYHT\" target=\"_blank\">TYHT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397457-shineco-reports-fy-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shineco reports FY results</a></h4><ul><li>Shineco (NASDAQ:<a href='https://seekingalpha.com/symbol/TYHT' title='Shineco, Inc.'>TYHT</a>): FY GAAP EPS of $0.36.</li><li>Revenue of $43.9M (+30.7% Y/Y)</li><li>Shares <font color='green'>+18.81%</font>.</li><li><a href='https://seekingalpha.com/pr/17301011-shineco-inc-reports-fiscal-year-2018-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3397457\" data-linked=\"Shineco reports FY results\" data-tweet=\"$TYHT - Shineco reports FY results https://seekingalpha.com/news/3397457-shineco-reports-fy-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3397457-shineco-reports-fy-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397456\" data-ts=\"1539635757\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMUC\" target=\"_blank\">IMUC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397456-immunocellular-therapeutics-to-delist-stock-shares-down-73-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ImmunoCellular Therapeutics to delist stock; shares down 73% after hours</a></h4><ul><li>Citing insurmountable operational headwinds, ImmunoCellular Therapeutics (<a href='https://seekingalpha.com/symbol/IMUC' title='ImmunoCellular Therapeutics, Ltd.'>OTCPK:IMUC</a>)<a href=\"https://seekingalpha.com/pr/17300934-immunocellular-therapeutics-announces-delisting-deregistration-common-stock-listed-common\" target=\"_blank\"> plans to file</a> a formal notification to NYSE American that it will voluntarily delist its common stock and common stock warrants. The notification, called a Form 25, should be effective on or about November 5.</li><li>Shares are down&nbsp;<font color='red'>73%</font>&nbsp;after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397456\" data-linked=\"ImmunoCellular Therapeutics to delist stock; shares down 73% after hours\" data-tweet=\"$IMUC - ImmunoCellular Therapeutics to delist stock; shares down 73% after hours https://seekingalpha.com/news/3397456-immunocellular-therapeutics-to-delist-stock-shares-down-73-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3397456-immunocellular-therapeutics-to-delist-stock-shares-down-73-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397448\" data-ts=\"1539635391\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JBHT\" target=\"_blank\">JBHT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397448-j-b-hunt-transport-lower-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">J.B. Hunt Transport lower after earnings</a></h4><ul> <li>J.B. Hunt Transport Services (NASDAQ:<a href='https://seekingalpha.com/symbol/JBHT' title='J.B. Hunt Transport Services, Inc.'>JBHT</a>) is <font color='red'>down 2.0%</font> in AH trading after a slight miss with Q3 revenue.</li> <li>Revenue breakdown: Intermodal  +16% to $1.22B, Dedicated contract services +24% to $543M, Integrated capacity solutions +28% to $346M, Truck +14% to $106M.</li> <li>Operating income breakdown: Intermodal +10% to $120M, Dedicated contract services +24% to $543M, Integrated capacity solutions +40% to $10M, Truck +61% to $9.2M.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3397430-j-b-hunt-transport-services-beats-0_07-misses-revenue\" target=\"_blank\">J.B. Hunt Transport Services beats by $0.07, misses on revenue</a> (Oct. 15)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3397448\" data-linked=\"J.B. Hunt Transport lower after earnings\" data-tweet=\"$JBHT - J.B. Hunt Transport lower after earnings https://seekingalpha.com/news/3397448-j-b-hunt-transport-lower-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3397448-j-b-hunt-transport-lower-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397440\" data-ts=\"1539634917\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADBE\" target=\"_blank\">ADBE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397440-adobe-reaffirms-q4-guidance-fy19-growth-targets\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Adobe reaffirms Q4 guidance, FY19 growth targets</a></h4><ul><li>        Adobe Systems (NASDAQ:<a href='https://seekingalpha.com/symbol/ADBE' title='Adobe Systems Incorporated'>ADBE</a>) <a href=\"https://seekingalpha.com/pr/17300923-adobe-outlines-growth-strategy-adobe-max\" target=\"_blank\">reaffirms</a> that it&rsquo;s on track to achieve Q4 revenue of $2.42B (consensus: $2.43B) and EPS of $1.87 (consensus: $1.89).</li><li>               FY19 growth targets: Revenue, +20% Y/Y; Digital Media revenue, +20% Y/Y; Digital Experience revenue, +20% Y/Y; Digital Media ARR (net new), $1.4B.&nbsp;</li><li>               Adobe shares are&nbsp;<font color='green'>up 4%</font>&nbsp;aftermarket to $247.40.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3397254-adobe-max-conference-starts-today\" target=\"_blank\">Adobe MAX conference starts today</a> (Oct. 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3397440\" data-linked=\"Adobe reaffirms Q4 guidance, FY19 growth targets\" data-tweet=\"$ADBE - Adobe reaffirms Q4 guidance, FY19 growth targets https://seekingalpha.com/news/3397440-adobe-reaffirms-q4-guidance-fy19-growth-targets?source=tweet\" data-url=\"https://seekingalpha.com/news/3397440-adobe-reaffirms-q4-guidance-fy19-growth-targets\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397432\" data-ts=\"1539634240\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACRS\" target=\"_blank\">ACRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397432-aclaris-acquires-rosacea-cream-from-allergan-for-65m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aclaris acquires rosacea cream from Allergan for $65M</a></h4><ul><li>Aclaris Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ACRS' title='Aclaris Therapeutics'>ACRS</a>) has <a href=\"https://seekingalpha.com/pr/17300902-aclaris-therapeutics-acquire-worldwide-rights-rhofade-allergan\" target=\"_blank\">agreed to acquire</a> global rights to Allergan's (NYSE:<a href='https://seekingalpha.com/symbol/AGN' title='Allergan plc'>AGN</a>) RHOFADE (oxymetazoline hydrochloride) cream 1%, indicated for the topical treatment of facial redness associated with rosacea in adults.</li><li>Under the terms of the deal, Alcaris will pay Allergan $65M at closing, a development milestone related to the advancement of an additional dermatology product and tiered royalties on net sales. The transaction should close this quarter.</li><li>Allergan acquired the product when it bought Vicept Therapeutics in 2011. Vicept was founded by certain members of Alcaris' senior management team.</li><li>Shares, currently halted, will resume trading at 4:30 pm ET.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397432\" data-linked=\"Aclaris acquires rosacea cream from Allergan for $65M\" data-tweet=\"$ACRS $ACRS $AGN - Aclaris acquires rosacea cream from Allergan for $65M https://seekingalpha.com/news/3397432-aclaris-acquires-rosacea-cream-from-allergan-for-65m?source=tweet\" data-url=\"https://seekingalpha.com/news/3397432-aclaris-acquires-rosacea-cream-from-allergan-for-65m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397421\" data-ts=\"1539632474\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GOLD\" target=\"_blank\">GOLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397421-gold-continues-moving-higher-marks-best-settlement-since-late-july\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gold continues moving higher, marks best settlement since late July</a></h4><ul>     <li>Comex gold futures rose modestly, closing <font color='green'>+0.7%</font> at $1,230.30/oz., but it was enough to send the yellow metal to its <a href=\"https://www.marketwatch.com/story/gold-advances-tests-territory-last-visited-in-july-2018-10-15\" target=\"_blank\">highest finish for a most-active contract since July 31</a>.</li>     <li>\"We have a <a href=\"https://www.cnbc.com/2018/10/15/gold-buyers-are-back-and-the-metal-could-go-higher.html\" target=\"_blank\">bullish outlook</a> through the end of the year and into next year,\" says HSBC precious metals analyst Jim Steel. \"Our average is $1,274/oz. this year, which means we'd continue to have a drive up  into the end of the year.\"</li><li>Last week's stock market selloff has been a factor in gold's rise, as well as the drop in the 10-year yield from a recent 3.25% back to 3.15%, says Bart Melek, head of commodities strategy at TD Securities, but the  risk-off move may have given way to another catalyst: \"Now there's a  view the Fed might not be as aggressive\" in raising rates, he says.</li><li>Meanwhile, last week&rsquo;s positive reversal for gold left much of the market wrong-footed, helping accelerate the move, according to Saxo Bank's Ole Hansen.</li><li>Gold mining stocks are broadly higher: ABX <font color='green'>+2.4%</font>, <a href='https://seekingalpha.com/symbol/NEM' title='Newmont Mining Corporation &#40;Holding Company&#41;'>NEM</a> <font color='green'>+2.2%</font>, <a href='https://seekingalpha.com/symbol/GOLD' title='Barrick Gold Corporation'>GOLD</a> <font color='green'>+2.7%</font>, <a href='https://seekingalpha.com/symbol/AEM' title='Agnico Eagle Mines Limited'>AEM</a> <font color='green'>+2.3%</font>, <a href='https://seekingalpha.com/symbol/GG' title='Goldcorp Inc.'>GG</a> <font color='green'>+0.9%</font>, <a href='https://seekingalpha.com/symbol/FNV' title='Franco-Nevada Corporation'>FNV</a> <font color='green'>+1.4%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/GLD' title='SPDR Gold Trust ETF'>GLD</a>, <a href='https://seekingalpha.com/symbol/GDX' title='VanEck Vectors Gold Miners ETF'>GDX</a>, <a href='https://seekingalpha.com/symbol/NUGT' title='Direxion Daily Gold Miners Index Bull 3x Shares ETF'>NUGT</a>, <a href='https://seekingalpha.com/symbol/GGN' title='GAMCO Global Gold, Natural Resources & Income Trust'>GGN</a>, <a href='https://seekingalpha.com/symbol/DUST' title='Direxion Daily Gold Miners Index Bear 3x Shares ETF'>DUST</a>, <a href='https://seekingalpha.com/symbol/IAU' title='iShares Gold Trust ETF'>IAU</a>, <a href='https://seekingalpha.com/symbol/PHYS' title='Sprott Physical Gold Trust'>PHYS</a>, <a href='https://seekingalpha.com/symbol/SGOL' title='Aberdn Std Gold Shs'>SGOL</a>, <a href='https://seekingalpha.com/symbol/GOEX' title='Global X Gold Explorers ETF'>GOEX</a>, <a href='https://seekingalpha.com/symbol/UGLD' title='VelocityShares 3x Long Gold ETN'>UGLD</a>, <a href='https://seekingalpha.com/symbol/SGDM' title='Sprott Gold Miners ETF'>SGDM</a>, <a href='https://seekingalpha.com/symbol/UGL' title='ProShares Ultra Gold ETF'>UGL</a>, <a href='https://seekingalpha.com/symbol/DGP' title='DB Gold Double Long ETN'>DGP</a>, <a href='https://seekingalpha.com/symbol/GLL' title='ProShares UltraShort Gold ETF'>GLL</a>, <a href='https://seekingalpha.com/symbol/ASA' title='ASA Gold&Precious Metals'>ASA</a>, <a href='https://seekingalpha.com/symbol/GTU' title='Central Gold-Trust'>GTU</a>, <a href='https://seekingalpha.com/symbol/GLDI' title='Credit Suisse Gold Shares Covered Call ETN'>GLDI</a>, <a href='https://seekingalpha.com/symbol/OUNZ' title='VanEck Merk Gold Trust ETF'>OUNZ</a>, <a href='https://seekingalpha.com/symbol/RING' title='iShares MSCI Global Gold Miners ETF'>RING</a>, <a href='https://seekingalpha.com/symbol/DZZ' title='DB Gold Double Short ETN'>DZZ</a>, <a href='https://seekingalpha.com/symbol/DGL' title='Inv DB Mul-Sec Shs Invesco DB Gold Fund'>DGL</a>, <a href='https://seekingalpha.com/symbol/DGLD' title='VelocityShares 3x Inverse Gold ETN'>DGLD</a>, <a href='https://seekingalpha.com/symbol/TGLDX' title='Tocqueville Gold Fund No Load'>TGLDX</a>, <a href='https://seekingalpha.com/symbol/DGZ' title='DB Gold Short ETN'>DGZ</a>, <a href='https://seekingalpha.com/symbol/PSAU' title='Invesco Global Gold and Precious Metals Portfolio ETF'>PSAU</a>, <a href='https://seekingalpha.com/symbol/GOAU' title='U.S. Global GO GOLD and Precious Metal Miners ETF'>GOAU</a>, <a href='https://seekingalpha.com/symbol/GDXX' title='ProShares Ultra Gold Miners ETF'>GDXX</a>, <a href='https://seekingalpha.com/symbol/GYEN' title='AdvisorShares Gartman Gold/Yen ETF'>GYEN</a>, <a href='https://seekingalpha.com/symbol/BAR' title='GraniteShares Gold Trust ETF'>BAR</a>, <a href='https://seekingalpha.com/symbol/GEUR' title='AdvisorShares Gartman Gold/Euro ETF'>GEUR</a>, <a href='https://seekingalpha.com/symbol/GDXS' title='ProShares UltraShort Gold Miners ETF'>GDXS</a>, <a href='https://seekingalpha.com/symbol/GLDW' title='SPDR Long Dollar Gold Trust ETF'>GLDW</a>, <a href='https://seekingalpha.com/symbol/GHS' title='REX Gold Hedged S&P 500 ETF'>GHS</a>, <a href='https://seekingalpha.com/symbol/UBG' title='UBS ETRACS CMCI Gold Total Return ETN'>UBG</a>, <a href='https://seekingalpha.com/symbol/QGLDX' title='The Gold Bullion Strategy Fund Inv'>QGLDX</a>, <a href='https://seekingalpha.com/symbol/GHE' title='REX Gold Hedged FTSE Emerging Markets ETF'>GHE</a>, <a href='https://seekingalpha.com/symbol/MELT' title='Direxion Daily Gold Miners Index Bear 1x Shares ETF'>MELT</a>, <a href='https://seekingalpha.com/symbol/AAAU' title='Perth Mint Physical Gold ETF'>AAAU</a>, <a href='https://seekingalpha.com/symbol/GLDM' title='World Gold Shares SPDR Gold Minishares Trust ETF'>GLDM</a>, <a href='https://seekingalpha.com/symbol/IAUF' title='iShares Gold Strategy ETF'>IAUF</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3397421\" data-linked=\"Gold continues moving higher, marks best settlement since late July\" data-tweet=\"$GOLD $GOLD $NEM - Gold continues moving higher, marks best settlement since late July https://seekingalpha.com/news/3397421-gold-continues-moving-higher-marks-best-settlement-since-late-july?source=tweet\" data-url=\"https://seekingalpha.com/news/3397421-gold-continues-moving-higher-marks-best-settlement-since-late-july\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:41 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397415\" data-ts=\"1539630914\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JBHT\" target=\"_blank\">JBHT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397415-wells-fargo-picks-trucking-favorites\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wells Fargo picks trucking favorites</a></h4><ul> <li>Wells Fargo sees upside for select trucking brokerage and logistics stocks.</li> <li>\"We believe the market pullback presents opportunity to reposition into the names that we believe are better able to leverage the 2019 demand environment,\" advises WF.</li> <li>The firm sees upside from current levels for J.B. Hunt Transport Services (<a href='https://seekingalpha.com/symbol/JBHT' title='J.B. Hunt Transport Services, Inc.'>JBHT</a> <font color='green'>+2.4%</font>), Schneider National (<a href='https://seekingalpha.com/symbol/SNDR' title='Schneider National'>SNDR</a> <font color='green'>+2.3%</font>), Landstar Systems (<a href='https://seekingalpha.com/symbol/LSTR' title='Landstar System, Inc.'>LSTR</a> <font color='green'>+0.6%</font>) and XPO Logistics (<a href='https://seekingalpha.com/symbol/XPO' title='XPO Logistics, Inc'>XPO</a> <font color='green'>+1.4%</font>).</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3397031-checking-trucking-stocks\" target=\"_blank\">Checking in on trucking stocks</a> (Oct. 12)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3397415\" data-linked=\"Wells Fargo picks trucking favorites\" data-tweet=\"$JBHT $JBHT $SNDR - Wells Fargo picks trucking favorites https://seekingalpha.com/news/3397415-wells-fargo-picks-trucking-favorites?source=tweet\" data-url=\"https://seekingalpha.com/news/3397415-wells-fargo-picks-trucking-favorites\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397412\" data-ts=\"1539629939\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EBR\" target=\"_blank\">EBR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397412-bolsonaro-top-economic-adviser-favors-selling-eletrobras-generation-assets\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bolsonaro top economic adviser favors selling Eletrobras generation assets</a></h4><ul>     <li>Eletrobras (<a href='https://seekingalpha.com/symbol/EBR' title='Centrais Eletricas Brasileiras S.A. - Eletrobras'>EBR</a> <font color='green'>+4.6%</font>) is higher after the top economic adviser to Brazilian presidential front-runner Jair Bolsonaro said he <a href=\"https://www.reuters.com/article/us-brazil-election/bolsonaro-adviser-favors-selling-eletrobras-generation-assets-idUSKCN1MN0PV\" target=\"_blank\">favors selling off</a> some of the utility company's power generation assets.</li>     <li>EBR shares rallied following the clear lead Bolsonaro took in <a href=\"https://seekingalpha.com/news/3395723-petrobras-plus-14-percent-bolsonaro-election-strength-baml-upgrade\" target=\"_blank\">last weekend&rsquo;s first-round vote</a> but then <a href=\"https://seekingalpha.com/news/3396428-eletrobras-minus-12-percent-bolsonaro-says-unwilling-sell-power-assets\" target=\"_blank\">fell back</a> when Bolsonaro said he would privatize transmission and distribution units but not the generation of electricity.</li>     <li>But in comments to reporters, Paulo Guedes, Bolsonaro's economic guru, said he favored selling EBR generation assets rather than transmission assets, as \"there are many cases [for sales] of strong private generation.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3397412\" data-linked=\"Bolsonaro top economic adviser favors selling Eletrobras generation assets\" data-tweet=\"$EBR - Bolsonaro top economic adviser favors selling Eletrobras generation assets https://seekingalpha.com/news/3397412-bolsonaro-top-economic-adviser-favors-selling-eletrobras-generation-assets?source=tweet\" data-url=\"https://seekingalpha.com/news/3397412-bolsonaro-top-economic-adviser-favors-selling-eletrobras-generation-assets\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:58 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397411\" data-ts=\"1539629717\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCWX\" target=\"_blank\">SCWX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397411-technology-top-5-gainers-losers-of-2_55-pm-10-15-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 2.55 PM (10/15/2018)</a></h4><ul>     <li><strong>Gainers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/SCWX' title='SecureWorks Corp.'>SCWX</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/HRS' title='Harris Corporation'>HRS</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/NINE' title='Nine Energy Service, Inc.'>NINE</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/ZUO' title='Zuora, Inc.'>ZUO</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/DQ' title='DAQO New Energy Corp.'>DQ</a> <font color='green'>+9%</font>.</li>     <li><strong>Losers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/AWSM' title='Cool Holdings Inc.'>AWSM</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/BOXL' title='Boxlight'>BOXL</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/IDT' title='IDT Corporation'>IDT</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/USAT' title='USA Technologies, Inc.'>USAT</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/NEON' title='Neonode, Inc.'>NEON</a> <font color='red'>-6%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3397411\" data-linked=\"Technology - Top 5 Gainers / Losers as of 2.55 PM (10/15/2018)\" data-tweet=\"$SCWX $SCWX $LHX - Technology - Top 5 Gainers / Losers as of 2.55 PM (10/15/2018) https://seekingalpha.com/news/3397411-technology-top-5-gainers-losers-of-2_55-pm-10-15-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3397411-technology-top-5-gainers-losers-of-2_55-pm-10-15-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397409\" data-ts=\"1539628974\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PCG\" target=\"_blank\">PCG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397409-in-first-pg-and-e-cuts-power-to-87k-customers-over-wildfire-fears\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">In a first, PG&amp;E cuts power to 87K customers over wildfire fears</a></h4><ul>     <li>PG&amp;E&nbsp;(<a href='https://seekingalpha.com/symbol/PCG' title='PG&E Corporation'>PCG</a> <font color='green'>+1.8%</font>) took the unprecedented step over the weekend of <a href=\"https://finance.yahoo.com/news/power-switched-off-northern-california-amid-fire-fears-143504060.html\" target=\"_blank\">cutting electricity</a> for tens of thousands of customers in an attempt to prevent wildfires in its northern California service area during high winds and dry conditions.</li>     <li>Pacific Gas &amp;&nbsp;Electric says it began turning off the power for 87K customers Sunday night and that more could be put in the dark depending on the weather before it restores power tonight, although some residents will not get their electricity back until Tuesday.</li>     <li>The National Weather Service predicted winds gusting to 55 mph in the Sierra foothills east of Sacramento, and high winds were expected in the state's wine country north of San Francisco.</li>     <li>PG&amp;E said it made the decision to turn off power \"as a last resort given the extreme fire danger conditions these communities are experiencing.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3397409\" data-linked=\"In a first, PG&amp;E cuts power to 87K customers over wildfire fears\" data-tweet=\"$PCG - In a first, PG&amp;E cuts power to 87K customers over wildfire fears https://seekingalpha.com/news/3397409-in-first-pg-and-e-cuts-power-to-87k-customers-over-wildfire-fears?source=tweet\" data-url=\"https://seekingalpha.com/news/3397409-in-first-pg-and-e-cuts-power-to-87k-customers-over-wildfire-fears\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397406\" data-ts=\"1539628275\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CUBI\" target=\"_blank\">CUBI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397406-investor-day-presentation-sends-customers-bancorp-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Investor Day presentation sends Customers Bancorp lower</a></h4><ul><li>Checking the <a href=\"https://seekingalpha.com/filing/4200942\" target=\"_blank\">end of the presentation slides</a> finds some Q3 details. Among them is a $14.2M after-tax loss on the sale of $495M of securities during the quarter. There's also a $900K after-tax gain on discontinuing cash flow hedge and equity security impairments. Combined these will cut Q3 EPS by roughly $0.41.</li><li>Should the Flagship deal be terminated, there could be additional related costs.</li><li>Nicely higher earlier in the session, <a href='https://seekingalpha.com/symbol/CUBI' title='Customers Bancorp'>CUBI</a> now flat for the day.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397406\" data-linked=\"Investor Day presentation sends Customers Bancorp lower\" data-tweet=\"$CUBI - Investor Day presentation sends Customers Bancorp lower https://seekingalpha.com/news/3397406-investor-day-presentation-sends-customers-bancorp-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/3397406-investor-day-presentation-sends-customers-bancorp-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:31 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397404\" data-ts=\"1539627725\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KSU\" target=\"_blank\">KSU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397404-kansas-city-southernplus-3-after-deutsche-bank-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Kansas City Southern +3% after Deutsche Bank upgrade</a></h4><ul> <li>Kansas City Southern (NYSE:<a href='https://seekingalpha.com/symbol/KSU' title='Kansas City Southern'>KSU</a>)&nbsp;<font color='green'>tracks up 2.66%</font> after an upgrade from Deutsche Bank captures some attention.</li> <li>The DB note indicates that the firm sees the sell-off in the railroad stock as a little overdone. \"Post sell-off we now view shares as highly attractive in light of growth prospects,\" writes the analyst team.</li> <li>Shares of KSU have fallen off 11% over the last 30 days.</li><li>Sources: MarketWatch, Bloomberg</li> </ul><div class=\"tiny-share-widget\" data-id=\"3397404\" data-linked=\"Kansas City Southern +3% after Deutsche Bank upgrade\" data-tweet=\"$KSU - Kansas City Southern +3% after Deutsche Bank upgrade https://seekingalpha.com/news/3397404-kansas-city-southernplus-3-after-deutsche-bank-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3397404-kansas-city-southernplus-3-after-deutsche-bank-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397400\" data-ts=\"1539627037\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GORO\" target=\"_blank\">GORO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397400-energy-materials-top-5-gainers-losers-of-2-00-pm-10-15-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials  - Top 5 Gainers / Losers as of 2:00 PM (10/15/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/GORO' title='Gold Resource Corporation'>GORO</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/ANW' title='Aegean Marine Petroleum Network Inc.'>OTC:ANW</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/LONE' title='Lonestar Resources US Inc.'>LONE</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/AUG' title='Auryn Resources Inc.'>AUG</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/SDPI' title='Superior Drilling Products, Inc.'>SDPI</a> <font color='green'>+8%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/NCSM' title='NCS Multistage Holdings'>NCSM</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/BPT' title='BP Prudhoe Bay Royalty Trust'>BPT</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/JONE' title='Jones Energy, Inc.'>OTC:JONE</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/PEIX' title='Pacific Ethanol, Inc.'>PEIX</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/REN' title='Resolute Energy Corporation'>REN</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397400\" data-linked=\"Energy/Materials  - Top 5 Gainers / Losers as of 2:00 PM (10/15/2018)\" data-tweet=\"$GORO $GORO $ANW - Energy/Materials - Top 5 Gainers / Losers as of 2:00 PM (10/15/2018) https://seekingalpha.com/news/3397400-energy-materials-top-5-gainers-losers-of-2-00-pm-10-15-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3397400-energy-materials-top-5-gainers-losers-of-2-00-pm-10-15-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:10 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397394\" data-ts=\"1539626277\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LJPC\" target=\"_blank\">LJPC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397394-la-jolla-pharma-files-for-150m-mixed-shelf-offering-shares-down-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">La Jolla Pharma files for $150M mixed shelf offering; shares down 6%</a></h4><ul><li>La Jolla Pharmaceutical Company (<a href='https://seekingalpha.com/symbol/LJPC' title='La Jolla Pharmaceutical Co.'>LJPC</a> <font color='red'>-6.1%</font>) slips on below-average volume following the filing of a <a href=\"https://www.sec.gov/Archives/edgar/data/920465/000119312518298762/d635729ds3.htm\" target=\"_blank\">prospectus </a>for a $150M mixed shelf offering.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397394\" data-linked=\"La Jolla Pharma files for $150M mixed shelf offering; shares down 6%\" data-tweet=\"$LJPC - La Jolla Pharma files for $150M mixed shelf offering; shares down 6% https://seekingalpha.com/news/3397394-la-jolla-pharma-files-for-150m-mixed-shelf-offering-shares-down-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3397394-la-jolla-pharma-files-for-150m-mixed-shelf-offering-shares-down-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397392\" data-ts=\"1539626094\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VLRX\" target=\"_blank\">VLRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397392-valeritas-files-for-50m-stock-offering-shares-down-12\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Valeritas files for $50M stock offering; shares down 12%</a></h4><ul><li>Nano cap Valeritas Holdings (<a href='https://seekingalpha.com/symbol/VLRX' title='Valeritas Holdings, Inc.'>VLRX</a> <font color='red'>-11.8%</font>) is down on almost double normal volume on the heels of its <a href=\"https://www.sec.gov/Archives/edgar/data/1619250/000104746918006710/a2236908zs-1a.htm\" target=\"_blank\">preliminary prospectus</a> for a $50M stock offering, specifically, ~38M shares at an assumed price of $1.33.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397392\" data-linked=\"Valeritas files for $50M stock offering; shares down 12%\" data-tweet=\"$VLRX - Valeritas files for $50M stock offering; shares down 12% https://seekingalpha.com/news/3397392-valeritas-files-for-50m-stock-offering-shares-down-12?source=tweet\" data-url=\"https://seekingalpha.com/news/3397392-valeritas-files-for-50m-stock-offering-shares-down-12\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397388\" data-ts=\"1539625527\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PAR\" target=\"_blank\">PAR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397388-another-par-shareholder-wants-outright-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Another PAR shareholder wants an outright sale</a></h4><ul><li>        PAR (NYSE:<a href='https://seekingalpha.com/symbol/PAR' title='PAR Technology Corporation'>PAR</a>) shareholder Voss Capital <a href=\"https://seekingalpha.com/pr/17300587-voss-capital-delivers-letter-par-technology-corporation\" target=\"_blank\">writes</a> the board a letter agreeing with last week&rsquo;s letter from ADW Capital Management that the company should pursue an outright sale&nbsp;</li><li>        Voss says that PAR &ldquo;will likely never achieve fair market value for its potentially valuable assets without splitting those assets&rdquo; and that now is the time since &ldquo;the market is generously valuing both of the industries in which PAR operates.&rdquo;</li><li>               The letter highlights the July acquisition of POS company Level Up by GrubHub for $390M in cash and private company Toast&rsquo;s $115M capital raise. Last month, Global Payments acquired SICOM for $415M in cash.&nbsp;</li><li>PAR shares are&nbsp;<font color='green'>up 2.1%</font>&nbsp;to $21.39.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3396644-par-shareholder-writes-board-asking-sale\" target=\"_blank\">PAR shareholder writes board asking for sale</a> (Oct. 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3397388\" data-linked=\"Another PAR shareholder wants an outright sale\" data-tweet=\"$PAR - Another PAR shareholder wants an outright sale https://seekingalpha.com/news/3397388-another-par-shareholder-wants-outright-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3397388-another-par-shareholder-wants-outright-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397381\" data-ts=\"1539623118\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LENS\" target=\"_blank\">LENS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397381-presbia-continues-selloff-from-longer-approval-timeline-for-microlens-shares-down-18\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Presbia continues selloff from longer approval timeline for Microlens, shares down 18%</a></h4><ul><li>Ultra-thinly traded nano cap Presbia PLC (<a href='https://seekingalpha.com/symbol/LENS' title='Presbia'>LENS</a> <font color='red'>-17.9%</font>) is down on almost a 10x surge in volume, albeit on turnover of only 80K shares, adding to the down move that started last week after the company <a href=\"https://www.sec.gov/Archives/edgar/data/1591096/000156459018024212/lens-8k_20181005.htm\" target=\"_blank\">disclosed </a>that the expected FDA nod for its Flexivue Microlens may not happen for another year. Shares have slumped almost&nbsp;<font color='red'>40%</font>&nbsp;since then.</li><li>The company's original expectation was for U.S. approval this quarter based on 24-month data, followed by the submission of 36-month data in Q1 2019. The FDA notified it on October 5 that the 36-month results would be required for a complete review of the application. The company has until April 3, 2019 to submit the information, pushing potential approval into the last quarter of the year if all goes well.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397381\" data-linked=\"Presbia continues selloff from longer approval timeline for Microlens, shares down 18%\" data-tweet=\"$LENS - Presbia continues selloff from longer approval timeline for Microlens, shares down 18% https://seekingalpha.com/news/3397381-presbia-continues-selloff-from-longer-approval-timeline-for-microlens-shares-down-18?source=tweet\" data-url=\"https://seekingalpha.com/news/3397381-presbia-continues-selloff-from-longer-approval-timeline-for-microlens-shares-down-18\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:05 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397379\" data-ts=\"1539622776\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRG\" target=\"_blank\">SRG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397379-financials-top-5-gainers-losers-of-1-00-pm-10-15-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM (10/15/2018)</a></h4><ul><li><b>Gainers:&nbsp;</b><a href='https://seekingalpha.com/symbol/SRG' title='Seritage Growth Properties'>SRG</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/HCC' title='Warrior Met Coal'>HCC</a> <font color='green'>+6%</font>.</li><li><b>Losers: </b><a href='https://seekingalpha.com/symbol/CIFS' title='China Internet Nationwide Financial Services Inc.'>CIFS</a> <font color='red'>-23%</font>. <a href='https://seekingalpha.com/symbol/CLDC' title='China Lending Corporation'>CLDC</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/OXBR' title='Oxbridge Re Holdings Limited'>OXBR</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397379\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM (10/15/2018)\" data-tweet=\"$SRG $SRG $HCC - Financials - Top 5 Gainers / Losers as of 1:00 PM (10/15/2018) https://seekingalpha.com/news/3397379-financials-top-5-gainers-losers-of-1-00-pm-10-15-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3397379-financials-top-5-gainers-losers-of-1-00-pm-10-15-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397377\" data-ts=\"1539622483\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DQ\" target=\"_blank\">DQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397377-daqo-starts-pilot-production-polysilicon-plant-targets-lower-output-costs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Daqo starts pilot production at polysilicon plant, targets lower output costs</a></h4><ul>     <li>Daqo New Energy (<a href='https://seekingalpha.com/symbol/DQ' title='DAQO New Energy Corp.'>DQ</a> <font color='green'>+6.7%</font>) jumps after saying it has completed construction and installation of its Phase 3B polysilicon production facility in Shihezi, China, and has <a href=\"https://seekingalpha.com/pr/17299791-daqo-new-energy-begins-pilot-production-new-phase-3b-polysilicon-production-facility\" target=\"_blank\">begun pilot production</a>.</li>     <li>DQ expects the Phase 3B  facility will ramp up to full production capacity and expand its total production capacity to 30K metric tons by the end of Q1 2019.</li>     <li>DQ says Phase 4A capacity expansion project is under construction and is expected to begin pilot production in Q4 2019 and ramp up to full production in Q1 2020, which will expand total  production capacity to 70K metric tons/year.</li><li>When Phase 4A is fully ramped, DQ expects electricity rates will decrease further, lowering the overall total cost of polysilicon production for its Xinjiang facilities to $6.80/kg.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3397377\" data-linked=\"Daqo starts pilot production at polysilicon plant, targets lower output costs\" data-tweet=\"$DQ - Daqo starts pilot production at polysilicon plant, targets lower output costs https://seekingalpha.com/news/3397377-daqo-starts-pilot-production-polysilicon-plant-targets-lower-output-costs?source=tweet\" data-url=\"https://seekingalpha.com/news/3397377-daqo-starts-pilot-production-polysilicon-plant-targets-lower-output-costs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397376\" data-ts=\"1539621883\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CGC\" target=\"_blank\">CGC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397376-canopy-growth-takeover-of-hemp-researcher-ebbut-stokes-pot-stocks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Canopy Growth takeover of hemp researcher ebbut stokes pot stocks</a></h4><ul><li>Pot stocks have perked up in conjunction with Canopy Growth's (<a href='https://seekingalpha.com/symbol/CGC' title='Canopy Growth Corporation'>CGC</a> <font color='green'>+10.5%</font>) acquisition of Colorado-based hemp research outfit ebbu. The commencement of legal cannabis use in Canada on Wednesday, October 17, may have something to do with it as well.</li><li>Selected tickers: (<a href='https://seekingalpha.com/symbol/MJNA' title='Medical Marijuana, Inc.'>OTCPK:MJNA</a> <font color='green'>+2.2%</font>)(ACBFF <font color='green'>+8.8%</font>)(<a href='https://seekingalpha.com/symbol/PHOT' title='Growlife Inc.'>OTCQB:PHOT</a> <font color='green'>+13.9%</font>)(<a href='https://seekingalpha.com/symbol/CBIS' title='Cannabis Science, Inc.'>OTCPK:CBIS</a> <font color='green'>+5.5%</font>)(APHQF <font color='green'>+4.9%</font>)(<a href='https://seekingalpha.com/symbol/TRTC' title='Terra Tech Corp.'>OTCQX:TRTC</a> <font color='green'>+6.9%</font>)(<a href='https://seekingalpha.com/symbol/CRON' title='Cronos Group, Inc.'>CRON</a> <font color='green'>+11.8%</font>)(<a href='https://seekingalpha.com/symbol/TLRY' title='Tilray, Inc.'>TLRY</a> <font color='green'>+9.2%</font>)(<a href='https://seekingalpha.com/symbol/CANN' title='General Cannabis Corp.'>OTCQX:CANN</a> <font color='green'>+10.4%</font>)(<a href='https://seekingalpha.com/symbol/ERBB' title='American Green, Inc.'>OTCPK:ERBB</a>)(<a href='https://seekingalpha.com/symbol/GRNH' title='GreenGro Technologies, Inc.'>OTCPK:GRNH</a> <font color='green'>+0.7%</font>)(<a href='https://seekingalpha.com/symbol/PMCB' title='PharmaCyte Biotech, Inc.'>OTCQB:PMCB</a>)(<a href='https://seekingalpha.com/symbol/CVSI' title='CV Sciences, Inc.'>OTCQB:CVSI</a> <font color='green'>+10.3%</font>)(<a href='https://seekingalpha.com/symbol/MJ' title='ETFMG Alternative Harvest ETF'>MJ</a> <font color='green'>+6.2%</font>)(<a href='https://seekingalpha.com/symbol/HEMP' title='Hemp, Inc.'>OTCPK:HEMP</a> <font color='green'>+5.7%</font>)(<a href='https://seekingalpha.com/symbol/CBDS' title='Cannabis Sativa, Inc.'>OTCQB:CBDS</a> <font color='green'>+21.9%</font>)(<a href='https://seekingalpha.com/symbol/BLOZF' title='Cannabix Technologies Inc.'>OTCPK:BLOZF</a> <font color='green'>+1.2%</font>)(<a href='https://seekingalpha.com/symbol/KSHB' title='KushCo Holdings, Inc.'>OTCQB:KSHB</a> <font color='green'>+3.1%</font>)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3397313-canopy-growth-acquire-ebbu\" target=\"_blank\">Canopy Growth to acquire ebbu</a> (Oct. 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3397376\" data-linked=\"Canopy Growth takeover of hemp researcher ebbut stokes pot stocks\" data-tweet=\"$CGC $CGC $MJNA - Canopy Growth takeover of hemp researcher ebbut stokes pot stocks https://seekingalpha.com/news/3397376-canopy-growth-takeover-of-hemp-researcher-ebbut-stokes-pot-stocks?source=tweet\" data-url=\"https://seekingalpha.com/news/3397376-canopy-growth-takeover-of-hemp-researcher-ebbut-stokes-pot-stocks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>67&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397373\" data-ts=\"1539621494\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KRYS\" target=\"_blank\">KRYS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397373-midday-gainers-losers-10-15-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (10/15/2018)</a></h4><ul>     <li><strong>Gainers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/KRYS' title='Krystal Biotech'>KRYS</a> <font color='green'>+29%</font>. <a href='https://seekingalpha.com/symbol/ABCD' title='Cambium Learning Group, Inc.'>ABCD</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/SLS' title='SELLAS Life Sciences Group, Inc.'>SLS</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/YGYI' title='Youngevity International, Inc.'>YGYI</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/XTLB' title='XTL Biopharmaceuticals Ltd.'>XTLB</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/ANIX' title='Anixa Biosciences, Inc.'>ANIX</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/SCWX' title='SecureWorks Corp.'>SCWX</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/LLL' title='L3 Technologies'>LLL</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/CGC' title='Canopy Growth Corporation'>CGC</a> <font color='green'>+11%</font>.</li>     <li><strong>Losers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/SNGX' title='Soligenix, Inc.'>SNGX</a> <font color='red'>-27%</font>. <a href='https://seekingalpha.com/symbol/LENS' title='Presbia'>LENS</a> <font color='red'>-25%</font>. <a href='https://seekingalpha.com/symbol/CIFS' title='China Internet Nationwide Financial Services Inc.'>CIFS</a> <font color='red'>-24%</font>. <a href='https://seekingalpha.com/symbol/AWSM' title='Cool Holdings Inc.'>AWSM</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/CVU' title='CPI Aerostructures, Inc'>CVU</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/CLDC' title='China Lending Corporation'>CLDC</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/ASCMA' title='Ascent Capital Group, Inc.'>ASCMA</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/VLRX' title='Valeritas Holdings, Inc.'>VLRX</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/NTRI' title='Nutrisystem Inc'>NTRI</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/NCSM' title='NCS Multistage Holdings'>NCSM</a> <font color='red'>-13%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3397373\" data-linked=\"Midday Gainers / Losers (10/15/2018)\" data-tweet=\"$KRYS $KRYS $ABCD - Midday Gainers / Losers (10/15/2018) https://seekingalpha.com/news/3397373-midday-gainers-losers-10-15-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3397373-midday-gainers-losers-10-15-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397369\" data-ts=\"1539620612\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LYSCF\" target=\"_blank\">LYSCF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397369-ft-ceo-says-lynas-seeks-alternatives-malaysia-plant-faces-threat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FT: CEO says Lynas seeks alternatives as Malaysia plant faces threat</a></h4><ul>     <li>Lynas (<a href='https://seekingalpha.com/symbol/LYSCF' title='Lynas Corp. Ltd.'>OTCPK:LYSCF</a> <font color='red'>-3.3%</font>) is <a href=\"https://www.ft.com/content/76e29afa-ccff-11e8-b276-b9069bde0956\" target=\"_blank\">searching for alternative locations</a> in case it is forced to  close its rare earths plant in Malaysia after a government review, CEO Amanda Lacaze tells the <em>Financial Times</em>.</li>     <li>Lacaze says the company is evaluating options in case a negative environmental review forced the closing of its A$1B plant in Kuantan.</li>     <li><em>FT</em> also says Malaysian MP Fuziah Salleh said she resigned her chairmanship from the committee reviewing the Lynas plant, but it is unclear if Malaysia&rsquo;s energy minister has accepted the resignation or if a replacement has been named.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3397369\" data-linked=\"FT: CEO says Lynas seeks alternatives as Malaysia plant faces threat\" data-tweet=\"$LYSCF - FT: CEO says Lynas seeks alternatives as Malaysia plant faces threat https://seekingalpha.com/news/3397369-ft-ceo-says-lynas-seeks-alternatives-malaysia-plant-faces-threat?source=tweet\" data-url=\"https://seekingalpha.com/news/3397369-ft-ceo-says-lynas-seeks-alternatives-malaysia-plant-faces-threat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397365\" data-ts=\"1539620206\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XRX\" target=\"_blank\">XRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397365-tech-lunch-break-netflix-apple-lead-back-down\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tech lunch break: Netflix, Apple lead back down</a></h4><ul><li>        The Technology Select Sector SPDR Fund (NYSEARCA:<a href='https://seekingalpha.com/symbol/XLK' title='Technology Select Sector SPDR ETF'>XLK</a>) is&nbsp;<font color='red'>down 1.1%.&nbsp;</font>S&amp;P 500 IT Index is&nbsp;<font color='red'>down 1.2%</font>. The tech heavy Nasdaq 100&nbsp;<font color='red'>drops 1%</font>&nbsp;and the Philadelphia Semiconductor Index is&nbsp;<font color='red'>down 0.5%</font>.</li><li>                  Movers with no clear catalysts: (<a href='https://seekingalpha.com/symbol/XRX' title='Xerox Corporation'>XRX</a> <font color='green'>+1.9%</font>), (<a href='https://seekingalpha.com/symbol/DBD' title='Diebold Nixdorf'>DBD</a> <font color='red'>-0.5%</font>), (<a href='https://seekingalpha.com/symbol/KOPN' title='Kopin Corporation'>KOPN</a> <font color='green'>+2.4%</font>), (<a href='https://seekingalpha.com/symbol/SYMC' title='Symantec Corporation'>SYMC</a> <font color='green'>+1%</font>).<br />   </li><li>        Internet and Software stocks are feeling the most pressure with Netflix&nbsp;<font color='red'>-2.2%</font>&nbsp;down ahead of earnings, Adobe&nbsp;<font color='red'>-3.3%&nbsp;</font>down on its event day, and Hortonworks&nbsp;<font color='red'>-3.4%&nbsp;</font>and Cloudera<font color='red'> -3.1%</font>&nbsp;pulling back from their post-merger announcement gains. Apple&nbsp;<font color='red'>-2.1%</font>&nbsp;is also weighing down FAANG after a negative analyst note this morning about Chinese demand.&nbsp;</li><li>Related Internet and Software ETFs: <a href='https://seekingalpha.com/symbol/FDN' title='First Trust DJ Internet Index ETF'>FDN</a>, <a href='https://seekingalpha.com/symbol/IGV' title='iShares Expanded Tech-Software Sector ETF'>IGV</a>, <a href='https://seekingalpha.com/symbol/PSJ' title='Invesco Dynamic Software Portfolio ETF'>PSJ</a>, <a href='https://seekingalpha.com/symbol/XSW' title='SPDR Software & Services ETF'>XSW</a>, <a href='https://seekingalpha.com/symbol/XWEB' title='SPDR S&P Internet ETF'>XWEB</a>, <a href='https://seekingalpha.com/symbol/FNGD' title='BMO REX MicroSectors FANG+ Index -3X Inverse Leveraged ETN'>FNGD</a>, <a href='https://seekingalpha.com/symbol/FNGU' title='BMO REX MicroSector FANG+ Index 3X Leveraged ETN'>FNGU</a></li><li>Top tech stories this morning: &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3397254-adobe-max-conference-starts-today\" target=\"_blank\">Adobe MAX conference starts today</a> (Oct. 15)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3397236-goldman-sees-rapidly-slowing-iphone-demand-china\" target=\"_blank\">Goldman sees \"rapidly slowing\" iPhone demand in China</a> (Oct. 15)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3397314-high-flying-pts-netflix-reeled\" target=\"_blank\">High-flying PTs on Netflix reeled in</a> (Oct. 15)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3397153-creation-l3-harris-technologies\" target=\"_blank\">The creation of L3 Harris Technologies</a> (Oct. 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3397365\" data-linked=\"Tech lunch break: Netflix, Apple lead back down\" data-tweet=\"$XRX $XLK $XRX - Tech lunch break: Netflix, Apple lead back down https://seekingalpha.com/news/3397365-tech-lunch-break-netflix-apple-lead-back-down?source=tweet\" data-url=\"https://seekingalpha.com/news/3397365-tech-lunch-break-netflix-apple-lead-back-down\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397362\" data-ts=\"1539619451\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YGYI\" target=\"_blank\">YGYI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397362-consumer-top-5-gainers-losers-of-12-00-pm-10-15-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top 5 Gainers / Losers as of 12:00 PM (10/15/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/YGYI' title='Youngevity International, Inc.'>YGYI</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/NIO' title='NIO'>NIO</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/WNC' title='Wabash National Corporation'>WNC</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/FUV' title='Arcimoto, Inc.'>FUV</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/ANFI' title='Amira Nature Foods'>ANFI</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/FTFT' title='Future Fintech Group Inc'>FTFT</a> <font color='red'>-5%</font>. <a href='https://seekingalpha.com/symbol/NAKD' title='Naked Brand Group Limited'>NAKD</a> <font color='red'>-5%</font>. <a href='https://seekingalpha.com/symbol/PYX' title='Pyxus International, Inc.'>PYX</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397362\" data-linked=\"Consumer - Top 5 Gainers / Losers as of 12:00 PM (10/15/2018)\" data-tweet=\"$YGYI $YGYI $NBEV - Consumer - Top 5 Gainers / Losers as of 12:00 PM (10/15/2018) https://seekingalpha.com/news/3397362-consumer-top-5-gainers-losers-of-12-00-pm-10-15-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3397362-consumer-top-5-gainers-losers-of-12-00-pm-10-15-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397355\" data-ts=\"1539617576\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OXY\" target=\"_blank\">OXY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397355-occidental-petroleumminus-4-after-qatar-says-will-take-over-oilfield\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Occidental Petroleum -4% after Qatar says it will take over oilfield</a></h4><ul>     <li>Occidental Petroleum (<a href='https://seekingalpha.com/symbol/OXY' title='Occidental Petroleum Corporation'>OXY</a> <font color='red'>-4.2%</font>) plunges after Qatar Petroleum says it will <a href=\"https://www.offshoreenergytoday.com/qatar-petroleum-taking-over-offshore-oil-field-from-oxy/\" target=\"_blank\">take over management and operation</a> of the Idd El-Shargi North Dome offshore oilfield upon next year's expiration of the 1994 production sharing agreement.</li>     <li>&ldquo;Managing and operating this important oil field showcases Qatar Petroleum&rsquo;s distinctive technical capabilities in operating and managing oil &amp; gas fields, and maximizes the value for the state,\"&nbsp;Qatar Petroleum says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3397355\" data-linked=\"Occidental Petroleum -4% after Qatar says it will take over oilfield\" data-tweet=\"$OXY - Occidental Petroleum -4% after Qatar says it will take over oilfield https://seekingalpha.com/news/3397355-occidental-petroleumminus-4-after-qatar-says-will-take-over-oilfield?source=tweet\" data-url=\"https://seekingalpha.com/news/3397355-occidental-petroleumminus-4-after-qatar-says-will-take-over-oilfield\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397354\" data-ts=\"1539617414\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YGYI\" target=\"_blank\">YGYI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397354-beverage-stocks-up-ahead-of-canada-marijuana-freedom\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Beverage stocks up ahead of Canada marijuana freedom</a></h4><ul> <li>Beverage stocks are tracking ahead of broad market averages on the day. It's possible some investors are eyeing the legalization of marijuana across Canada on October 17 as a catalyst this week.</li> <li>Notable gainers: Youngevity International (NASDAQ:<a href='https://seekingalpha.com/symbol/YGYI' title='Youngevity International, Inc.'>YGYI</a>) <font color='green'>+17.6%</font>, New Age Beverages (NASDAQ:<a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a>) <font color='green'>+9.9%</font>, Hexo Corp. (HYYDF) <font color='green'>+4.4%</font>, Celsisu Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/CELH' title='Celsius Holdings, Inc.'>CELH</a>) <font color='green'>+4.3%</font>, Castle Brands (NYSEMKT:<a href='https://seekingalpha.com/symbol/ROX' title='Castle Brands Inc'>ROX</a>) <font color='green'>+1.9%</font>, Reed's (NYSEMKT:<a href='https://seekingalpha.com/symbol/REED' title='Reed&#39;s, Inc.'>REED</a>) <font color='green'>+1.3%</font>, Boston Beer (NYSE:<a href='https://seekingalpha.com/symbol/SAM' title='Boston Beer Co.'>SAM</a>) <font color='green'>+1.2%</font>, PepsiCo (NYSE:<a href='https://seekingalpha.com/symbol/PEP' title='PepsiCo Inc.'>PEP</a>) <font color='green'>+1.0%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3397354\" data-linked=\"Beverage stocks up ahead of Canada marijuana freedom\" data-tweet=\"$YGYI $YGYI $NBEV - Beverage stocks up ahead of Canada marijuana freedom https://seekingalpha.com/news/3397354-beverage-stocks-up-ahead-of-canada-marijuana-freedom?source=tweet\" data-url=\"https://seekingalpha.com/news/3397354-beverage-stocks-up-ahead-of-canada-marijuana-freedom\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>32&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397353\" data-ts=\"1539617221\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PBYI\" target=\"_blank\">PBYI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397353-positive-kadcyla-data-pressures-puma-bio-down-5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Positive Kadcyla data pressures Puma Bio, down 5%</a></h4><ul><li>Puma Biotechnology (<a href='https://seekingalpha.com/symbol/PBYI' title='Puma Biotechnology, Inc.'>PBYI</a> <font color='red'>-5%</font>) is down on below-average volume in apparent reaction to Roche's (<a href='https://seekingalpha.com/symbol/RHHBY' title='Roche Holding Ltd ADR'>OTCQX:RHHBY</a> <font color='green'>+0.2%</font>) announcement of positive late-stage data on Kadcyla (ado-trastuzumab) as adjuvant treatment in patients with early-stage HER2-positive breast cancer. Puma's <a href=\"https://nerlynx.com/\" target=\"_blank\">Nerlynx </a>(neratinib) was OK'd in the U.S. in July 2017 for the same indication.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3397174-roches-kadcyla-beats-herceptin-late-stage-breast-cancer-study\" target=\"_blank\">Roche's Kadcyla beats Herceptin in late-stage breast cancer study</a> (Oct. 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3397353\" data-linked=\"Positive Kadcyla data pressures Puma Bio, down 5%\" data-tweet=\"$PBYI $PBYI $RHHBY - Positive Kadcyla data pressures Puma Bio, down 5% https://seekingalpha.com/news/3397353-positive-kadcyla-data-pressures-puma-bio-down-5?source=tweet\" data-url=\"https://seekingalpha.com/news/3397353-positive-kadcyla-data-pressures-puma-bio-down-5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397347\" data-ts=\"1539616424\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SLS\" target=\"_blank\">SLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397347-sellas-to-host-cc-october-22-on-final-results-from-mid-stage-study-of-neuvax-herceptin-in\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SELLAS to host CC October 22 on final results from mid-stage study of NeuVax + Herceptin in certain breast cancer patients; shares up 18%</a></h4><ul><li>Nano cap SELLAS Life Sciences Group (<a href='https://seekingalpha.com/symbol/SLS' title='SELLAS Life Sciences Group, Inc.'>SLS</a> <font color='green'>+18.4%</font>) is up more than a 4x surge in volume following its <a href=\"https://seekingalpha.com/pr/17300116-sellas-host-conference-call-following-oral-presentation-phase-2b-results-neuvax-herceptin\" target=\"_blank\">announcement </a>that it will host a conference call on Monday, October 22, at 8:00 am ET to discuss updated and final results from its Phase 2b clinical trial evaluating NeuVax (nelipepimut-S) plus Roche's (<a href='https://seekingalpha.com/symbol/RHHBY' title='Roche Holding Ltd ADR'>OTCQX:RHHBY</a> <font color='green'>+0.2%</font>) Herceptin (trastuzumab) in HER2 low-expressing breast cancer patients. The call will follow the presentation of the data at ESMO in Munich.</li><li>In early June, the company announced that the study was stopped early based on positive results.</li><li>#ESMO</li><li>Previously: <a href=\"https://seekingalpha.com/news/3361063-sellas-23-percent-premarket-early-termination-mid-stage-breast-cancer-study-neuvax-herceptin\" target=\"_blank\">SELLAS up 23% premarket on early termination of mid-stage breast cancer study of NeuVax + Herceptin</a> (June 1)</li></ul><div class=\"tiny-share-widget\" data-id=\"3397347\" data-linked=\"SELLAS to host CC October 22 on final results from mid-stage study of NeuVax + Herceptin in certain breast cancer patients; shares up 18%\" data-tweet=\"$SLS $SLS $RHHBY - SELLAS to host CC October 22 on final results from mid-stage study of NeuVax + Herceptin in certain breast cancer patients; shares up 18% https://seekingalpha.com/news/3397347-sellas-to-host-cc-october-22-on-final-results-from-mid-stage-study-of-neuvax-herceptin-in?source=tweet\" data-url=\"https://seekingalpha.com/news/3397347-sellas-to-host-cc-october-22-on-final-results-from-mid-stage-study-of-neuvax-herceptin-in\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397345\" data-ts=\"1539616234\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARRS\" target=\"_blank\">ARRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397345-arrisminus-3_9-raymond-james-leaves-strong-buy-behind\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ARRIS -3.9% as Raymond James leaves Strong Buy behind</a></h4><ul><li>        Raymond James downgrades ARRIS (NASDAQ:<a href='https://seekingalpha.com/symbol/ARRS' title='ARRIS International plc'>ARRS</a>) from Strong Buy to Outperform and cuts the target from $36 to $29, a 25% upside to Friday&rsquo;s close.</li><li>                  Source: StreetAccount. &nbsp;   </li><li>               ARRIS shares are&nbsp;<font color='red'>down 3.9%</font>&nbsp;to $22.24. Shares are&nbsp;<font color='red'>down 12.7%</font>&nbsp;in the past month as routers and modems ended up on the wrong side of the proposed tariffs on $200B in Chinese products.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3392294-modems-routers-slammed-new-u-s-tariffs-smart-tech-goods-escape\" target=\"_blank\">Modems, routers slammed by new U.S. tariffs but 'smart' tech goods escape</a> (Sept. 24)</li></ul><div class=\"tiny-share-widget\" data-id=\"3397345\" data-linked=\"ARRIS -3.9% as Raymond James leaves Strong Buy behind\" data-tweet=\"$ARRS - ARRIS -3.9% as Raymond James leaves Strong Buy behind https://seekingalpha.com/news/3397345-arrisminus-3_9-raymond-james-leaves-strong-buy-behind?source=tweet\" data-url=\"https://seekingalpha.com/news/3397345-arrisminus-3_9-raymond-james-leaves-strong-buy-behind\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397339\" data-ts=\"1539615651\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SLS\" target=\"_blank\">SLS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397339-healthcare-top-5-gainers-losers-of-11-00-10-15-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 AM (10/15/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/SLS' title='SELLAS Life Sciences Group, Inc.'>SLS</a> <font color='green'>+25%</font>. <a href='https://seekingalpha.com/symbol/KRYS' title='Krystal Biotech'>KRYS</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/XTLB' title='XTL Biopharmaceuticals Ltd.'>XTLB</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/ACRX' title='AcelRx Pharmaceuticals, Inc.'>ACRX</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/FCSC' title='Fibrocell Science, Inc.'>FCSC</a> <font color='green'>+10%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SNGX' title='Soligenix, Inc.'>SNGX</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/VLRX' title='Valeritas Holdings, Inc.'>VLRX</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/IOVA' title='Iovance Biotherapeutics, Inc.'>IOVA</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/ALT' title='Altimmune, Inc.'>ALT</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/ELOX' title='Eloxx Pharmaceuticals, Inc.'>ELOX</a> <font color='red'>-9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397339\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 AM (10/15/2018)\" data-tweet=\"$SLS $SLS $KRYS - Healthcare - Top 5 Gainers / Losers as of 11:00 AM (10/15/2018) https://seekingalpha.com/news/3397339-healthcare-top-5-gainers-losers-of-11-00-10-15-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3397339-healthcare-top-5-gainers-losers-of-11-00-10-15-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397337\" data-ts=\"1539615605\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANIX\" target=\"_blank\">ANIX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397337-anixa-bio-up-4-on-advancement-of-ai-based-prostate-cancer-test\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Anixa Bio up 4% on advancement of AI-based prostate cancer test</a></h4><ul><li>Thinly traded micro cap Anixa Biosciences (<a href='https://seekingalpha.com/symbol/ANIX' title='Anixa Biosciences, Inc.'>ANIX</a> <font color='green'>+4%</font>) is up on below-average volume in response to its <a href=\"https://seekingalpha.com/pr/17299814-anixa-biosciences-files-pre-submission-requests-meeting-fda-regarding-cchek-artificial\" target=\"_blank\">announcement </a>that it has filed an application with the FDA requesting a in-person meeting to clarify a regulatory path for <a href=\"https://www.anixa.com/cchek\" target=\"_blank\">Cchek</a>, an artificial intelligence &#40;AI&#41;-based cancer detection technology, as a test for prostate cancer.</li><li>Cchek uses AI to analyze flow cytometry data to distinguish between tumor-bearing and non-tumor bearing patients.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397337\" data-linked=\"Anixa Bio up 4% on advancement of AI-based prostate cancer test\" data-tweet=\"$ANIX - Anixa Bio up 4% on advancement of AI-based prostate cancer test https://seekingalpha.com/news/3397337-anixa-bio-up-4-on-advancement-of-ai-based-prostate-cancer-test?source=tweet\" data-url=\"https://seekingalpha.com/news/3397337-anixa-bio-up-4-on-advancement-of-ai-based-prostate-cancer-test\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397335\" data-ts=\"1539615172\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RSSS\" target=\"_blank\">RSSS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397335-research-solutions-submits-nasdaq-symbol-reservation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Research Solutions submits NASDAQ symbol reservation</a></h4><ul>     <li>Research Solutions (<a href='https://seekingalpha.com/symbol/RSSS' title='Research Solutions, Inc.'>OTCQB:RSSS</a> <font color='green'>+4.3%</font>) says that the Company has submitted a symbol reservation form as a prerequisite step to filing an application to list its common stock on the NASDAQ Capital Market.</li>     <li>The Company's common stock will continue to trade on the OTCQB under its current symbol \"RSSS\" until NASDAQ approval and completion of the up-listing.</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3397335\" data-linked=\"Research Solutions submits NASDAQ symbol reservation\" data-tweet=\"$RSSS - Research Solutions submits NASDAQ symbol reservation https://seekingalpha.com/news/3397335-research-solutions-submits-nasdaq-symbol-reservation?source=tweet\" data-url=\"https://seekingalpha.com/news/3397335-research-solutions-submits-nasdaq-symbol-reservation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397333\" data-ts=\"1539614984\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATVI\" target=\"_blank\">ATVI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397333-beijing-freeze-hangs-over-videogame-sector\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Beijing freeze hangs over videogame sector</a></h4><ul> <li>Activision Blizzard (<a href='https://seekingalpha.com/symbol/ATVI' title='Activision Blizzard, Inc'>ATVI</a> <font color='red'>-3.8%</font>), Electronic Arts (<a href='https://seekingalpha.com/symbol/EA' title='Electronic Arts Inc.'>EA</a> <font color='red'>-0.8%</font>) and Take-Two Interactive Software (<a href='https://seekingalpha.com/symbol/TTWO' title='Take-Two Interactive Software, Inc.'>TTWO</a> <font color='red'>-1.9%</font>) are all lower on heightened concerns over Beijing's freeze on new titles.</li> <li>Financial Times <a href=\"https://www.ft.com/content/9d7c1434-cc50-11e8-b276-b9069bde0956\" target=\"_blank\">reports</a> Chinese videogame execs don't expect the resumption of license approvals until sometime next year.</li> <li>Tencent Holdings (<a href='https://seekingalpha.com/symbol/TCEHY' title='Tencent Holding Ltd. ADR'>OTCPK:TCEHY</a>, <a href='https://seekingalpha.com/symbol/TCTZF' title='Tencent Holding Ltd.'>OTCPK:TCTZF</a>) closed <font color='red'>down 2%</font> in Hong Kong today, while the U.S. ADRs are&nbsp;<font color='red'>off ~5%</font>.</li> <li>Gaming chip manufacturer Nvidia is <font color='red'>down 3.37%</font> on the day.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397333\" data-linked=\"Beijing freeze hangs over videogame sector\" data-tweet=\"$ATVI $ATVI $EA - Beijing freeze hangs over videogame sector https://seekingalpha.com/news/3397333-beijing-freeze-hangs-over-videogame-sector?source=tweet\" data-url=\"https://seekingalpha.com/news/3397333-beijing-freeze-hangs-over-videogame-sector\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397330\" data-ts=\"1539614602\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AIMT\" target=\"_blank\">AIMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397330-aimmune-teams-up-regeneron-and-sanofi-in-mid-stage-peanut-allergy-study-shares-up-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aimmune teams up with Regeneron and Sanofi in mid-stage peanut allergy study; shares up 1%</a></h4><ul><li>Aimmune Therapeutics (<a href='https://seekingalpha.com/symbol/AIMT' title='Aimmune Therapeutics'>AIMT</a> <font color='green'>+1.3%</font>) is up on light volume on the heels of the <a href=\"https://seekingalpha.com/pr/17299960-aimmune-therapeutics-announces-initiation-phase-2-study-regeneron-sanofi-ar101-adjunctive\" target=\"_blank\">initiation </a>of a <a href=\"https://clinicaltrials.gov/ct2/show/NCT03682770?intr=Dupilumab%2C+AR101&amp;lead=regeneron&amp;phase=1&amp;rank=1\" target=\"_blank\">Phase 2 clinical trial</a> evaluating AR101 with adjunctive DUPIXENT (dupilumab) in peanut-allergy patients.</li><li>The study is being sponsored by Regeneron Pharmaceuticals (<a href='https://seekingalpha.com/symbol/REGN' title='Regeneron Pharmaceuticals, Inc.'>REGN</a> <font color='red'>-1.6%</font>) with AIMT providing product and food challenge materials. Target enrollment is 160 across 25 U.S. sites. The primary objective is to determine if the addition of dupilumab to AR101 therapy improves desensitization compared to placebo + AR101.</li><li>According to ClinicalTrials.gov, the estimated primary completion date is June 2020.</li><li>Related ticker: (<a href='https://seekingalpha.com/symbol/SNY' title='Sanofi'>SNY</a> <font color='green'>+1.7%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3397330\" data-linked=\"Aimmune teams up with Regeneron and Sanofi in mid-stage peanut allergy study; shares up 1%\" data-tweet=\"$AIMT $AIMT $REGN - Aimmune teams up with Regeneron and Sanofi in mid-stage peanut allergy study; shares up 1% https://seekingalpha.com/news/3397330-aimmune-teams-up-regeneron-and-sanofi-in-mid-stage-peanut-allergy-study-shares-up-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3397330-aimmune-teams-up-regeneron-and-sanofi-in-mid-stage-peanut-allergy-study-shares-up-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:43 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397328\" data-ts=\"1539614244\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MHK\" target=\"_blank\">MHK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397328-caution-dialed-up-on-mohawk-industries\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Caution dialed up on Mohawk Industries</a></h4><ul> <li>Mohawk Industries (<a href='https://seekingalpha.com/symbol/MHK' title='Mohawk Industries Inc.'>MHK</a> <font color='red'>-0.5%</font>) is on watch after catching a downgrade from RBC Capital Markets to Sector Perform from Outperform. RBC dropped its price target to $190 from $221.</li> <li>The flooring manufacturer was also reportedly <a href=\"https://www.streetinsider.com/Analyst+Comments/Mohawk+Industries+%28MHK%29+Mentioned+Cautiously+at+Short-Focused+Research+Firm/14704623.html\" target=\"_blank\">issued</a> a \"Red Flag\" warning from Pacific Square Research due to concerns over earnings.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3397328\" data-linked=\"Caution dialed up on Mohawk Industries\" data-tweet=\"$MHK - Caution dialed up on Mohawk Industries https://seekingalpha.com/news/3397328-caution-dialed-up-on-mohawk-industries?source=tweet\" data-url=\"https://seekingalpha.com/news/3397328-caution-dialed-up-on-mohawk-industries\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397324\" data-ts=\"1539613766\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GNMX\" target=\"_blank\">GNMX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397324-aevi-genomic-medicine-advancing-mid-stage-study-of-aeviminus-001-in-adhd-shares-up-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aevi Genomic Medicine advancing mid-stage study of AEVI-001 in ADHD; shares up 2%</a></h4><ul><li>Thinly traded nano cap Aevi Genomic Medicine (<a href='https://seekingalpha.com/symbol/GNMX' title='Aevi Genomic Medicine, Inc.'>GNMX</a> <font color='green'>+1.9%</font>) is up on below-average volume following its announcement that <a href=\"https://clinicaltrials.gov/ct2/show/NCT03609619?lead=aevi+genomic+medicine&amp;phase=1&amp;rank=1\" target=\"_blank\">Part B</a> of its Phase 2 ASCEND study evaluating AEVI-001 in pediatric and adolescent patients with attention deficit hyperactivity disorder &#40;ADHD&#41; is now fully enrolled.</li><li>Topline data from both <a href=\"https://clinicaltrials.gov/ct2/show/NCT03265119?lead=aevi+genomic+medicine&amp;phase=1&amp;rank=2\" target=\"_blank\">Part A</a> (enrollment completed in August) and Part B should be available in January 2019.</li><li>AEVI-001 is an oral non-stimulant pan-selective activator/modulator of metabotropic glutamate receptors (mGluRs) that bind glutamate, a molecule that plays a key role in nerve cell signaling. <a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2904507/\" target=\"_blank\">MGluRs </a>are promising drug targets for a range of disorders beyond ADHD, such as Alzheimer's disease, Parkinson's disease, anxiety, depression and schizophrenia.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397324\" data-linked=\"Aevi Genomic Medicine advancing mid-stage study of AEVI-001 in ADHD; shares up 2%\" data-tweet=\"$GNMX - Aevi Genomic Medicine advancing mid-stage study of AEVI-001 in ADHD; shares up 2% https://seekingalpha.com/news/3397324-aevi-genomic-medicine-advancing-mid-stage-study-of-aeviminus-001-in-adhd-shares-up-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3397324-aevi-genomic-medicine-advancing-mid-stage-study-of-aeviminus-001-in-adhd-shares-up-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:29 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397317\" data-ts=\"1539612848\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ORGS\" target=\"_blank\">ORGS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397317-orgenesis-up-6_5-post-q3-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Orgenesis up 6.5% post Q3 results</a></h4><ul><li>Orgenesis (<a href='https://seekingalpha.com/symbol/ORGS' title='Orgenesis, Inc.'>ORGS</a> <font color='green'>+6.5%</font>) reports&nbsp;<a href=\"https://seekingalpha.com/pr/17300137-orgenesis-reports-143-percent-increase-revenue-316-percent-increase-gross-profit-third\" target=\"_blank\">Q3</a>&nbsp;revenue growth of 138.5% Y/Y to $6.2M.</li><li>Gross margin&nbsp;<font color='green'>increased 2,023 bps</font>&nbsp;to 46.8%.</li><li>CDMO segment recorded an operating profit of $2.1M.</li><li>Operating loss was $0.65M for Q3, as compared to $3.4M Y/Y.</li><li>Quarter ended with $16.7M of cash and ~$30M of shareholders&rsquo; equity.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3397242-orgenesis-reports-q3-results\" target=\"_blank\">Orgenesis reports Q3 results</a> (Oct. 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3397317\" data-linked=\"Orgenesis up 6.5% post Q3 results\" data-tweet=\"$ORGS - Orgenesis up 6.5% post Q3 results https://seekingalpha.com/news/3397317-orgenesis-up-6_5-post-q3-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3397317-orgenesis-up-6_5-post-q3-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397315\" data-ts=\"1539612675\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DCTH\" target=\"_blank\">DCTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397315-delcath-adds-six-sites-to-study-of-melphalan-hds-in-ocular-melanoma-shares-ahead-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Delcath adds six sites to study of Melphalan/HDS in ocular melanoma; shares ahead 2%</a></h4><ul><li>Delcath Systems (<a href='https://seekingalpha.com/symbol/DCTH' title='Delcath Systems, Inc.'>OTC:DCTH</a> <font color='green'>+2%</font>) has<a href=\"https://seekingalpha.com/pr/17300052-delcath-expands-rollout-registration-trial-metastatic-ocular-melanoma\" target=\"_blank\"> added six additional centers</a> to its registration study evaluating Melphalan/HDS in patients with ocular melanoma liver metastases.</li><li>Patient enrollment should be completed in H1 2019.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397315\" data-linked=\"Delcath adds six sites to study of Melphalan/HDS in ocular melanoma; shares ahead 2%\" data-tweet=\"$DCTH - Delcath adds six sites to study of Melphalan/HDS in ocular melanoma; shares ahead 2% https://seekingalpha.com/news/3397315-delcath-adds-six-sites-to-study-of-melphalan-hds-in-ocular-melanoma-shares-ahead-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3397315-delcath-adds-six-sites-to-study-of-melphalan-hds-in-ocular-melanoma-shares-ahead-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397307\" data-ts=\"1539611811\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LOGM\" target=\"_blank\">LOGM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397307-logmeinminus-2_1-on-piper-target-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">LogMeIn -2.1% on Piper target cut</a></h4><ul><li>        Piper Jaffray lowers its LogMeIn (NASDAQ:<a href='https://seekingalpha.com/symbol/LOGM' title='LogMeIn, Inc.'>LOGM</a>) target from $95 to $90 and maintains a Neutral rating.</li><li>               Price cut comes ahead of the earnings report expected on October 25.&nbsp;</li><li>               Source: StreetAccount.&nbsp;</li><li>               LogMeIn shares are&nbsp;<font color='red'>down 2.1%</font>&nbsp;to $80.99. LOGM is trading&nbsp;<font color='red'>down 25.3%</font>&nbsp;in the quarter and&nbsp;<font color='red'>27.8%</font>&nbsp;YTD.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3397307\" data-linked=\"LogMeIn -2.1% on Piper target cut\" data-tweet=\"$LOGM - LogMeIn -2.1% on Piper target cut https://seekingalpha.com/news/3397307-logmeinminus-2_1-on-piper-target-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3397307-logmeinminus-2_1-on-piper-target-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:56 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397305\" data-ts=\"1539611651\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHLDQ\" target=\"_blank\">SHLDQ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397305-carving-up-sears-and-toys-r-us-holiday-sales\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Carving up Sears and Toys &quot;R&quot; Us holiday sales</a></h4><ul> <li>After the bankruptcy filings of Sears Holdings (SHLD <font color='red'>-13.8%</font>) and Toys \"R\" Us, the <a href=\"https://www.wsj.com/articles/profiting-off-a-sears-bankruptcy-not-so-simple-for-rivals-1539439200\" target=\"_blank\">spotlight</a> turns to where the retailers' holiday sales will go this year.</li> <li>Analysts think Target (<a href='https://seekingalpha.com/symbol/TGT' title='Target Corporation'>TGT</a> <font color='red'>-0.1%</font>), Amazon (<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a> <font color='red'>-1.9%</font>), Dollar Tree (<a href='https://seekingalpha.com/symbol/DLTR' title='Dollar Tree, Inc.'>DLTR</a> <font color='red'>-0.8%</font>) and Walmart (<a href='https://seekingalpha.com/symbol/WMT' title='Walmart Inc.'>WMT</a> <font color='red'>-0.4%</font>)&nbsp;will gobble up the most toy sales, while Sears appliance sales are seen going to Home Depot (<a href='https://seekingalpha.com/symbol/HD' title='Home Depot, Inc.'>HD</a>), Lowe's (<a href='https://seekingalpha.com/symbol/LOW' title='Lowe&#39;s Companies, Inc.'>LOW</a> <font color='red'>-0.2%</font>) and Best Buy (<a href='https://seekingalpha.com/symbol/BBY' title='Best Buy Co.'>BBY</a> <font color='green'>+1.5%</font>).</li> <li>Apparel sales out of Sears aren't expected to transfer over to department store rivals at quite the same rate, although incremental gains are seen for J.C. Penney (<a href='https://seekingalpha.com/symbol/JCP' title='J.C. Penney Company Inc.'>JCP</a> <font color='red'>-4%</font>), Macy's (<a href='https://seekingalpha.com/symbol/M' title='Macy&#39;s Inc.'>M</a> <font color='green'>+0.6%</font>) and Kohl's (<a href='https://seekingalpha.com/symbol/KSS' title='Kohl&#39;s Corporation'>KSS</a> <font color='red'>-0.3%</font>).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3397305\" data-linked=\"Carving up Sears and Toys &quot;R&quot; Us holiday sales\" data-tweet=\"$SHLDQ $SHLDQ $TGT - Carving up Sears and Toys &quot;R&quot; Us holiday sales https://seekingalpha.com/news/3397305-carving-up-sears-and-toys-r-us-holiday-sales?source=tweet\" data-url=\"https://seekingalpha.com/news/3397305-carving-up-sears-and-toys-r-us-holiday-sales\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>67&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397299\" data-ts=\"1539611178\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LUVU\" target=\"_blank\">LUVU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397299-on-luvu-brands-q4-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Luvu Brands Q4 results</a></h4><ul><li>Luvu Brands (<a href='https://seekingalpha.com/symbol/LUVU' title='Luvu Brands, Inc.'>OTCQB:LUVU</a>) reports&nbsp;<a href=\"https://seekingalpha.com/pr/17299850-luvu-brands-reports-fiscal-2018-results\" target=\"_blank\">Q4</a>&nbsp;revenue growth of 6.3% Y/Y to $3.9M.</li><li>Gross margin&nbsp;<font color='green'>increased 185 bps&nbsp;</font>to 28.9%.</li><li>$0.2M in income from operations, compared to a loss from operations of $1K Y/Y.</li><li>Adj. EBITDA margin for fiscal 2018&nbsp;<font color='red'>declined 367 bps&nbsp;</font>to 22.8%.</li><li>&ldquo;Our focus in fiscal 2019 continues to be on improving our production efficiencies and gross profit margins and ramping up production in order to keep pace with the continued demand&rdquo;, said President and CEO,&nbsp;Louis Friedman.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3397193-luvu-brands-reports-q4-results\" target=\"_blank\">Luvu Brands reports Q4 results</a> (Oct. 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3397299\" data-linked=\"More on Luvu Brands Q4 results\" data-tweet=\"$LUVU - More on Luvu Brands Q4 results https://seekingalpha.com/news/3397299-on-luvu-brands-q4-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3397299-on-luvu-brands-q4-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397297\" data-ts=\"1539610984\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ANET\" target=\"_blank\">ANET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397297-cisco-dips-analyst-says-arista-networks-got-contract\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cisco dips as analyst says Arista Networks got its contract</a></h4><ul><li>        William Blair analyst Jason Ader is out positive on Arista Networks (<a href='https://seekingalpha.com/symbol/ANET' title='Arista Networks, Inc.'>ANET</a> <font color='green'>+1.2%</font>) saying that the firm&rsquo;s contact reports the company was recently awarded a Department of Defense contract worth $100M over multiple years. Cisco (<a href='https://seekingalpha.com/symbol/CSCO' title='Cisco Systems, Inc.'>CSCO</a> <font color='red'>-0.9%</font>) previously had the award and is now protesting.</li><li>               Ader says the contract win should be seen as a &ldquo;game-changer&rdquo; for the &ldquo;underpenetrated federal business&rdquo; and should boost the chances for future government awards.&nbsp;</li><li>                  Rating maintained at Outperform.    </li><li>               Source: StreetAccount.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3397297\" data-linked=\"Cisco dips as analyst says Arista Networks got its contract\" data-tweet=\"$ANET $ANET $CSCO - Cisco dips as analyst says Arista Networks got its contract https://seekingalpha.com/news/3397297-cisco-dips-analyst-says-arista-networks-got-contract?source=tweet\" data-url=\"https://seekingalpha.com/news/3397297-cisco-dips-analyst-says-arista-networks-got-contract\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397294\" data-ts=\"1539610680\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PZZA\" target=\"_blank\">PZZA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397294-papa-johns-expected-to-show-sales-improvement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Papa John&#39;s expected to show sales improvement</a></h4><ul> <li>Papa John's (NASDAQ:<a href='https://seekingalpha.com/symbol/PZZA' title='Papa John&#39;s International, Inc.'>PZZA</a>) comparable sales started to recover in the middle of September, according to Longbow Research (per Bloomberg).</li> <li>The improvement coincided with a new marketing plan by the pizza chain and a clearer break from founder John Schnatter.</li> <li>Shares of Papa John's are <font color='green'>up 1.04%</font> premarket to $53.46 vs. a 52-week trading range of $38.05 to $71.28.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3397294\" data-linked=\"Papa John&#39;s expected to show sales improvement\" data-tweet=\"$PZZA - Papa John&#39;s expected to show sales improvement https://seekingalpha.com/news/3397294-papa-johns-expected-to-show-sales-improvement?source=tweet\" data-url=\"https://seekingalpha.com/news/3397294-papa-johns-expected-to-show-sales-improvement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:38 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397291\" data-ts=\"1539610654\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APOP\" target=\"_blank\">APOP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397291-cellects-apograft-shows-encouraging-action-in-early-stage-study-shares-up-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cellect&#39;s ApoGraft shows encouraging action in early-stage study; shares up 1%</a></h4><ul><li>Thinly traded nano cap Cellect Biotechnology (<a href='https://seekingalpha.com/symbol/APOP' title='Cellect Biotechnology Ltd.'>APOP</a>) is in the green out the gate this morning on the heels of its <a href=\"https://seekingalpha.com/pr/17299885-cellect-announces-positive-clinical-results\" target=\"_blank\">announcement </a>of positive preliminary data from a Phase 1/2 clinical trial evaluating its ApoGraft stem cell selection technology in patients undergoing stem cell transplantation.</li><li>One-month data on six patients showed 100% engraftment with no procedure-related adverse events reported. Also, the first three patients (cohort 1) have safely completed the 180-day study period with no tolerability issues.</li><li>According to the company, ApoGraft significantly reduces the risk of life-threatening rejection disease and other unwanted immune responses by separating the stem cells needed for transplant from those that cause the adverse effects.</li><li>Enrollment in the third cohort (of four) is underway.</li><li>Shares are up&nbsp;<font color='green'>1%</font>&nbsp;in early trade.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397291\" data-linked=\"Cellect&#39;s ApoGraft shows encouraging action in early-stage study; shares up 1%\" data-tweet=\"$APOP - Cellect&#39;s ApoGraft shows encouraging action in early-stage study; shares up 1% https://seekingalpha.com/news/3397291-cellects-apograft-shows-encouraging-action-in-early-stage-study-shares-up-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3397291-cellects-apograft-shows-encouraging-action-in-early-stage-study-shares-up-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397289\" data-ts=\"1539610505\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MRVL\" target=\"_blank\">MRVL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397289-bmo-upgrades-marvell-technology-to-outperform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BMO upgrades Marvell Technology to Outperform</a></h4><ul><li>        BMO Capital Markets upgrades Marvell Tech (NASDAQ:<a href='https://seekingalpha.com/symbol/MRVL' title='Marvell Technology Group, Ltd.'>MRVL</a>) from Market Perform to Outperform with a $24 price target, a 33% upside to Friday&rsquo;s close. (Source: StreetAccount.)</li><li>               Last week, Stifel upgraded the company to Buy on its data center prospects and the fact that the recent sell-off made for a good entry point.&nbsp;</li><li>               Marvell shares are&nbsp;<font color='green'>up 0.33%</font>&nbsp;today,&nbsp;<font color='red'>down 3.2%</font>&nbsp;in the week,&nbsp;<font color='red'>2.9%</font>&nbsp;in the month, nearly&nbsp;<font color='red'>15%</font>&nbsp;in the quarter, and&nbsp;<font color='red'>16%&nbsp;</font>YTD.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3396888-marvell-stifel-rates-buy-data-center-prospects\" target=\"_blank\">Marvell up as Stifel rates Buy on data-center prospects</a> (Oct. 11)</li></ul><div class=\"tiny-share-widget\" data-id=\"3397289\" data-linked=\"BMO upgrades Marvell Technology to Outperform\" data-tweet=\"$MRVL - BMO upgrades Marvell Technology to Outperform https://seekingalpha.com/news/3397289-bmo-upgrades-marvell-technology-to-outperform?source=tweet\" data-url=\"https://seekingalpha.com/news/3397289-bmo-upgrades-marvell-technology-to-outperform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397287\" data-ts=\"1539610317\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NIO\" target=\"_blank\">NIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397287-nio-updates-on-deliveries\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NIO updates on deliveries</a></h4><ul> <li>NIO (<a href='https://seekingalpha.com/symbol/NIO' title='NIO'>NIO</a> <font color='green'>+5.2%</font>) announces that YTD deliveries of its ES8 model is at 3,368 units.</li><li>Delivery volume of the ES8 was 1,766 in September alone.</li><li>The EV automaker started ES8 deliveries on June 28.</li><li>NIO says it's on track to hit its production target of 10K ES8s&nbsp;in the second half of the year, despite a planned production transition that will slow down the process this month.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17299697-nio-inc-delivered-1766-es8-vehicles-month-september-2018-3268-vehicles-third-quarter-2018\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3397287\" data-linked=\"NIO updates on deliveries\" data-tweet=\"$NIO - NIO updates on deliveries https://seekingalpha.com/news/3397287-nio-updates-on-deliveries?source=tweet\" data-url=\"https://seekingalpha.com/news/3397287-nio-updates-on-deliveries\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>33&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397284\" data-ts=\"1539609739\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HMNY\" target=\"_blank\">HMNY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397284-proxy-advisors-back-reverse-split-helios-and-matheson-analytics\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Proxy advisors back reverse split at Helios and Matheson Analytics</a></h4><ul> <li>Helios and Matheson Analytics (NASDAQ:<a href='https://seekingalpha.com/symbol/HMNY' title='Helios and Matheson Analytics, Inc.'>HMNY</a>) says it has the backing of&nbsp;independent proxy advisory firms       ISS and Glass, Lewis &amp; Co. for the proposed reverse       stock split and the other proposal set forth in its proxy statement       for the upcoming special meeting of stockholders scheduled for October       18.</li><li>Helios is aiming to keep its Nasdaq listing through the reverse split.</li><li>HMNY  <font color='green'>+5.78%</font> premarket to  $0.0183.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17300257-leading-independent-proxy-advisory-firms-iss-glass-lewis-recommend-helios-matheson-analytics\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3397284\" data-linked=\"Proxy advisors back reverse split at Helios and Matheson Analytics\" data-tweet=\"$HMNY - Proxy advisors back reverse split at Helios and Matheson Analytics https://seekingalpha.com/news/3397284-proxy-advisors-back-reverse-split-helios-and-matheson-analytics?source=tweet\" data-url=\"https://seekingalpha.com/news/3397284-proxy-advisors-back-reverse-split-helios-and-matheson-analytics\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397282\" data-ts=\"1539609576\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VTGN\" target=\"_blank\">VTGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397282-vistagen-adds-expert-in-social-anxiety-disorder-ahead-of-phase-3-development-of-ph94b-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VistaGen adds expert in social anxiety disorder ahead of Phase 3 development of PH94B; shares up 4% premarket</a></h4><ul><li>Nano cap VistaGen Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/VTGN' title='VistaGen Therapeutics, Inc.'>VTGN</a>) is up&nbsp;<font color='green'>4%&nbsp;</font>premarket following its <a href=\"https://seekingalpha.com/pr/17300123-vistagen-therapeutics-appoints-dr-michael-liebowitz-cns-clinical-regulatory-advisory-board\" target=\"_blank\">announcement </a>that social anxiety disorder &#40;SAD&#41; expert Michael Liebowitz, M.D. has joined its CNS Clinical and Regulatory Advisory Board ahead of the launch of Phase 3 development for <a href=\"https://www.vistagen.com/pipeline/social-anxiety-disorder\" target=\"_blank\">PH94B</a>, a potential on-demand nasal spray for the condition.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397282\" data-linked=\"VistaGen adds expert in social anxiety disorder ahead of Phase 3 development of PH94B; shares up 4% premarket\" data-tweet=\"$VTGN - VistaGen adds expert in social anxiety disorder ahead of Phase 3 development of PH94B; shares up 4% premarket https://seekingalpha.com/news/3397282-vistagen-adds-expert-in-social-anxiety-disorder-ahead-of-phase-3-development-of-ph94b-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3397282-vistagen-adds-expert-in-social-anxiety-disorder-ahead-of-phase-3-development-of-ph94b-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:19 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397281\" data-ts=\"1539609528\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACRX\" target=\"_blank\">ACRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397281-premarket-gainers-of-9-05-10-15-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am (10/15/2018)</a></h4><ul><li><a href='https://seekingalpha.com/symbol/ACRX' title='AcelRx Pharmaceuticals, Inc.'>ACRX</a> <font color='green'>+21%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3397185-acelrx-pharma-29-percent-premarket-positive-ad-com-vote-dsuvia\" target=\"_blank\">positive</a> Ad Com vote for Dsuvia and positive analyst <a href=\"https://seekingalpha.com/news/3397204-premarket-analyst-action-healthcare\" target=\"_blank\">action</a>.</li><li><a href='https://seekingalpha.com/symbol/ABCD' title='Cambium Learning Group, Inc.'>ABCD</a> <font color='green'>+19%</font>&nbsp;on merger <a href=\"https://seekingalpha.com/pr/17299749-cambium-learning-group-enters-definitive-merger-agreement-veritas-capital\" target=\"_blank\">agreement</a> with Veritas Capital.</li><li><a href='https://seekingalpha.com/symbol/SLS' title='SELLAS Life Sciences Group, Inc.'>SLS</a> <font color='green'>+11%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17300116-sellas-host-conference-call-following-oral-presentation-phase-2b-results-neuvax-herceptin\" target=\"_blank\">presenting</a> interim and updated final clinical data of Phase 2b Results of NeuVax + Herceptin.</li><li><a href='https://seekingalpha.com/symbol/RKDA' title='Arcadia Biosciences'>RKDA</a> <font color='green'>+10%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3397163-arcadia-biosciences-receives-us-patent-extended-shelf-life-wheat-trait\" target=\"_blank\">receiving</a> US patent for extended shelf life wheat trait.</li><li><a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a> <font color='green'>+7%</font>.</li><li><a href='https://seekingalpha.com/symbol/PEIX' title='Pacific Ethanol, Inc.'>PEIX</a> <font color='green'>+8%</font>.</li><li><a href='https://seekingalpha.com/symbol/NXTD' title='NXT-ID Inc.'>NXTD</a> <font color='green'>+7%</font>.</li><li><a href='https://seekingalpha.com/symbol/CRON' title='Cronos Group, Inc.'>CRON</a> <font color='green'>+7%</font>&nbsp;on partnering with Technion Research &amp; Development Foundation for cannabinoid-based skin care treatments.</li><li><a href='https://seekingalpha.com/symbol/INO' title='Inovio Pharmaceuticals, Inc.'>INO</a> <font color='green'>+7%</font>&nbsp;on encouraging Ebola vaccine <a href=\"https://seekingalpha.com/news/3397260-inovio-pharma-7-percent-premarket-encouraging-ebola-vaccine-data\" target=\"_blank\">data</a>.</li><li><a href='https://seekingalpha.com/symbol/SBGL' title='Sibanye-Stillwater'>SBGL</a> <font color='green'>+7%</font>&nbsp;on better <a href=\"https://seekingalpha.com/news/3397276-south-african-miners-pop-sibanye-stillwater-plus-7-percent-premarket\" target=\"_blank\">outlook</a>.</li><li><a href='https://seekingalpha.com/symbol/LLL' title='L3 Technologies'>LLL</a> <font color='green'>+6%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3397153-creation-l3-harris-technologies\" target=\"_blank\">merger</a> with Harris.</li><li><a href='https://seekingalpha.com/symbol/TLRY' title='Tilray, Inc.'>TLRY</a> <font color='green'>+5%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17299724-high-park-company-introduces-comprehensive-portfolio-adult-use-cannabis-brands\" target=\"_blank\">launching</a> comprehensive portfolio of adult-use cannabis brands.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397281\" data-linked=\"Premarket Gainers as of 9:05 am (10/15/2018)\" data-tweet=\"$ACRX $ACRX $ABCD - Premarket Gainers as of 9:05 am (10/15/2018) https://seekingalpha.com/news/3397281-premarket-gainers-of-9-05-10-15-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3397281-premarket-gainers-of-9-05-10-15-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397276\" data-ts=\"1539609074\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBGL\" target=\"_blank\">SBGL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397276-south-african-miners-pop-sibanye-stillwaterplus-7-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">South African miners pop; Sibanye-Stillwater +7% premarket</a></h4><ul>     <li>Sibanye-Stillwater (NYSE:<a href='https://seekingalpha.com/symbol/SBGL' title='Sibanye-Stillwater'>SBGL</a>)&nbsp;<font color='green'>+6.8%</font> pre-market and surging as much as 20% on the Johannesburg Stock  Exchange, a development the company says is reflective of its &ldquo;<a href=\"https://www.miningmx.com/top-story/34688-sibanye-stillwater-vaults-as-much-as-22-on-another-day-of-gold-share-gains/\" target=\"_blank\">better outlook</a>.\"</li>     <li>&ldquo;We are recovering from the significant negativity from the first quarter and the market is starting to reflect the better outlook,&rdquo; says SBGL's head of investor relations.</li><li>Traders say the improvement is part of a wider appreciation in  South African gold shares and not related to a short squeeze; other South African miners also are higher pre-market: <a href='https://seekingalpha.com/symbol/HMY' title='Harmony Gold Mining Company Limited'>HMY</a> <font color='green'>+4.9%</font>, <a href='https://seekingalpha.com/symbol/AU' title='AngloGold Ashanti Limited'>AU</a> <font color='green'>+3.9%</font>, <a href='https://seekingalpha.com/symbol/GFI' title='Gold Fields Limited'>GFI</a> <font color='green'>+2.5%</font>.</li><li>SBGL has surged 16% <a href=\"https://seekingalpha.com/news/3396775-sibanye-stillwater-plus-11-percent-goldman-sees-continued-gains\" target=\"_blank\">since Thursday</a>, when Goldman Sachs said the stock was \"materially undervalued.\"</li><li>Morgan Stanley says it also favors SBGL because the stock &ldquo;trades at a material  discount to its sum of the parts and where valuation is ignoring sources  of optionality,&rdquo; and AU's premium relative to South African peers is &ldquo;warranted&rdquo; because of its  diversification and lower cost of production.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/GLD' title='SPDR Gold Trust ETF'>GLD</a>, <a href='https://seekingalpha.com/symbol/IAU' title='iShares Gold Trust ETF'>IAU</a>, <a href='https://seekingalpha.com/symbol/PHYS' title='Sprott Physical Gold Trust'>PHYS</a>, <a href='https://seekingalpha.com/symbol/SGOL' title='Aberdn Std Gold Shs'>SGOL</a>, <a href='https://seekingalpha.com/symbol/UGLD' title='VelocityShares 3x Long Gold ETN'>UGLD</a>, <a href='https://seekingalpha.com/symbol/UGL' title='ProShares Ultra Gold ETF'>UGL</a>, <a href='https://seekingalpha.com/symbol/DGP' title='DB Gold Double Long ETN'>DGP</a>, <a href='https://seekingalpha.com/symbol/GLL' title='ProShares UltraShort Gold ETF'>GLL</a>, <a href='https://seekingalpha.com/symbol/GTU' title='Central Gold-Trust'>GTU</a>, <a href='https://seekingalpha.com/symbol/GLDI' title='Credit Suisse Gold Shares Covered Call ETN'>GLDI</a>, <a href='https://seekingalpha.com/symbol/OUNZ' title='VanEck Merk Gold Trust ETF'>OUNZ</a>, <a href='https://seekingalpha.com/symbol/DZZ' title='DB Gold Double Short ETN'>DZZ</a>, <a href='https://seekingalpha.com/symbol/DGL' title='Inv DB Mul-Sec Shs Invesco DB Gold Fund'>DGL</a>, <a href='https://seekingalpha.com/symbol/DGLD' title='VelocityShares 3x Inverse Gold ETN'>DGLD</a>, <a href='https://seekingalpha.com/symbol/DGZ' title='DB Gold Short ETN'>DGZ</a>, <a href='https://seekingalpha.com/symbol/GYEN' title='AdvisorShares Gartman Gold/Yen ETF'>GYEN</a>, <a href='https://seekingalpha.com/symbol/BAR' title='GraniteShares Gold Trust ETF'>BAR</a>, <a href='https://seekingalpha.com/symbol/GEUR' title='AdvisorShares Gartman Gold/Euro ETF'>GEUR</a>, <a href='https://seekingalpha.com/symbol/GLDW' title='SPDR Long Dollar Gold Trust ETF'>GLDW</a>, <a href='https://seekingalpha.com/symbol/GHS' title='REX Gold Hedged S&P 500 ETF'>GHS</a>, <a href='https://seekingalpha.com/symbol/UBG' title='UBS ETRACS CMCI Gold Total Return ETN'>UBG</a>, <a href='https://seekingalpha.com/symbol/QGLDX' title='The Gold Bullion Strategy Fund Inv'>QGLDX</a>, <a href='https://seekingalpha.com/symbol/GHE' title='REX Gold Hedged FTSE Emerging Markets ETF'>GHE</a>, <a href='https://seekingalpha.com/symbol/AAAU' title='Perth Mint Physical Gold ETF'>AAAU</a>, <a href='https://seekingalpha.com/symbol/GLDM' title='World Gold Shares SPDR Gold Minishares Trust ETF'>GLDM</a>, <a href='https://seekingalpha.com/symbol/IAUF' title='iShares Gold Strategy ETF'>IAUF</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3397276\" data-linked=\"South African miners pop; Sibanye-Stillwater +7% premarket\" data-tweet=\"$SBGL $SBGL $HMY - South African miners pop; Sibanye-Stillwater +7% premarket https://seekingalpha.com/news/3397276-south-african-miners-pop-sibanye-stillwaterplus-7-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3397276-south-african-miners-pop-sibanye-stillwaterplus-7-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397275\" data-ts=\"1539609040\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCHW\" target=\"_blank\">SCHW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397275-schwab-rises-1-premarket-q3-matches-consensus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Schwab rises 1% premarket as Q3 matches consensus</a></h4><ul><li>Charles Schwab (NYSE:<a href='https://seekingalpha.com/symbol/SCHW' title='The Charles Schwab Corporation'>SCHW</a>)&nbsp;<font color='green'>gains 1%&nbsp;</font>in premarket trading as <a href=\"https://seekingalpha.com/pr/17300188-schwab-reports-record-quarterly-net-income-923-million-49-percent\" target=\"_blank\">Q3 EPS of 65 cents</a> matches consensus and net interest revenue of $1.53B rose 9% from Q2 and 41% from a year ago.</li><li>Q3 revenue trades of $382M rose 2% from $376M in Q2 and 22% from $312M in Q3 2017. Average revenue per trade fell to $7.27 in Q3 from $7.30 in Q2, and $7.74 in the year-ago quarter.</li><li>Q3 asset management and administration fees of $809M fell 8% from Q2 and 1% Y/Y.</li><li>Q3 pretax profit margin 47.3% vs. 45.5% in Q2 and 43.6% in Q3 2017.</li><li>Q3 return on average common stockholders' equity (as annualized) 20%, its highest ROE in nine year, vs. 19% in Q2 and 15% a year ago.</li><li>Clients opened 369,000 brokerage accounts inQ3, bringing YTD new accounts to 1.2M--the highest nine-month total in Schwab's history.</li><li>\"The company&rsquo;s consolidated balance sheet reached $272B at month-end September, a $10B quarterly increase, largely driven by bank sweep transfers and client activity,\" says CEO Walt Bettinger.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3397253-charles-schwab-eps-revenue-line\" target=\"_blank\">Charles Schwab EPS and revenue in-line</a> (Oct. 15)</li></ul><div class=\"tiny-share-widget\" data-id=\"3397275\" data-linked=\"Schwab rises 1% premarket as Q3 matches consensus\" data-tweet=\"$SCHW - Schwab rises 1% premarket as Q3 matches consensus https://seekingalpha.com/news/3397275-schwab-rises-1-premarket-q3-matches-consensus?source=tweet\" data-url=\"https://seekingalpha.com/news/3397275-schwab-rises-1-premarket-q3-matches-consensus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397271\" data-ts=\"1539608881\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CIFS\" target=\"_blank\">CIFS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397271-premarket-losers-of-9-05-10-15-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am (10/15/2018)</a></h4><ul><li><a href='https://seekingalpha.com/symbol/CIFS' title='China Internet Nationwide Financial Services Inc.'>CIFS</a> <font color='red'>-15%</font>.</li><li><a href='https://seekingalpha.com/symbol/GRIN' title='Grindrod Shipping Holdings Ltd.'>GRIN</a> <font color='red'>-8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3397271\" data-linked=\"Premarket Losers as of 9:05 am (10/15/2018)\" data-tweet=\"$CIFS $CIFS $GRIN - Premarket Losers as of 9:05 am (10/15/2018) https://seekingalpha.com/news/3397271-premarket-losers-of-9-05-10-15-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3397271-premarket-losers-of-9-05-10-15-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:08 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397270\" data-ts=\"1539608756\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AEO\" target=\"_blank\">AEO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397270-american-eagle-outfitters-rallies-after-wedbush-lift\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Eagle Outfitters rallies after Wedbush lift</a></h4><ul> <li>Wedbush lifts American Eagle Outfitters (NYSE:<a href='https://seekingalpha.com/symbol/AEO' title='American Eagle Outfitters, Inc.'>AEO</a>) to an Outperform rating from Neutral on the expectation for a strong Q3 and full holiday season.</li> <li>Analyst Jen Redding and team lift the FY18 EPS estimate on AEO to $1.58 vs. $1.48 consensus and the FY19 EPS on $1.78 vs. $1.63 consensus.</li> <li>Shares of American Eagle are <font color='green'>up 2.54%</font> in premarket trading to $21.81.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3397270\" data-linked=\"American Eagle Outfitters rallies after Wedbush lift\" data-tweet=\"$AEO - American Eagle Outfitters rallies after Wedbush lift https://seekingalpha.com/news/3397270-american-eagle-outfitters-rallies-after-wedbush-lift?source=tweet\" data-url=\"https://seekingalpha.com/news/3397270-american-eagle-outfitters-rallies-after-wedbush-lift\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397268\" data-ts=\"1539608627\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XTLB\" target=\"_blank\">XTLB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397268-xtl-bio-perks-up-28-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">XTL Bio perks up 28% premarket</a></h4><ul><li>Ultra-thinly traded nano cap XTL Biopharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/XTLB' title='XTL Biopharmaceuticals Ltd.'>XTLB</a>) is the latest tiny biotech to rally, up&nbsp;<font color='green'>28%</font>&nbsp;premarket on average volume, albeit on turnover of only 5,700 shares.</li><li>No particular news accounts for the action, but the company may be a candidate for a capital infusion. At the end of June, it had ~$5.5M in quick assets. Net income was $875K in Q2.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397268\" data-linked=\"XTL Bio perks up 28% premarket\" data-tweet=\"$XTLB - XTL Bio perks up 28% premarket https://seekingalpha.com/news/3397268-xtl-bio-perks-up-28-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3397268-xtl-bio-perks-up-28-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397261\" data-ts=\"1539608126\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTN\" target=\"_blank\">MTN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397261-vail-resorts-skis-higher-after-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vail Resorts skis higher after upgrade</a></h4><ul> <li>Vail Resorts (NYSE:<a href='https://seekingalpha.com/symbol/MTN' title='Vail Resorts, Inc.'>MTN</a>) tracks higher after Macquarie lifts the resort operator to an Outperform rating from Neutral on a positive view of current valuation.</li> <li>Macquarie sees strong season pass growth for Vail this year and beyond.</li> <li>The firm has a price target of $300 on Vail vs. the 52-week trading range of $200.68 to $302.76.</li> <li>MTN <font color='green'>+1.55%</font> premarket to $249.67.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3397261\" data-linked=\"Vail Resorts skis higher after upgrade\" data-tweet=\"$MTN - Vail Resorts skis higher after upgrade https://seekingalpha.com/news/3397261-vail-resorts-skis-higher-after-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3397261-vail-resorts-skis-higher-after-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:55 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397260\" data-ts=\"1539608114\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INO\" target=\"_blank\">INO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397260-inovio-pharma-up-7-premarket-on-encouraging-ebola-vaccine-data\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inovio Pharma up 7% premarket on encouraging Ebola vaccine data</a></h4><ul><li>Inovio Pharmaceuticals (NYSEMKT:<a href='https://seekingalpha.com/symbol/INO' title='Inovio Pharmaceuticals, Inc.'>INO</a>) is up&nbsp;<font color='green'>7%</font>&nbsp;premarket on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/17300018-inovio-s-ebola-vaccine-provides-100-percent-protection-elicits-long-lasting-immune-responses\" target=\"_blank\">announcement </a>of positive preclinical data on its Ebola vaccine INO-4212.</li><li>INO-4212, administered via IM injection in one study, elicited 100% protection against a lethal Ebola challenge. In another study, two intradermal injections of the vaccine candidate also provided 100% protection from a lethal Ebola challenge (both involved monkeys).</li><li>In a previously completed Phase 1 study in healthy humans, the vaccine produced an Ebola-specific antibody immune response in 95% (n=170/179) of participants.</li><li>The company says it is working with collaborators and potential new funders to advance INO-4212.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397260\" data-linked=\"Inovio Pharma up 7% premarket on encouraging Ebola vaccine data\" data-tweet=\"$INO - Inovio Pharma up 7% premarket on encouraging Ebola vaccine data https://seekingalpha.com/news/3397260-inovio-pharma-up-7-premarket-on-encouraging-ebola-vaccine-data?source=tweet\" data-url=\"https://seekingalpha.com/news/3397260-inovio-pharma-up-7-premarket-on-encouraging-ebola-vaccine-data\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397257\" data-ts=\"1539607900\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTRI\" target=\"_blank\">NTRI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397257-nutrisystemminus-7-after-da-davidson-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nutrisystem -7% after DA Davidson cut</a></h4><ul> <li>Shares of Nutrisystem (NASDAQ:<a href='https://seekingalpha.com/symbol/NTRI' title='Nutrisystem Inc'>NTRI</a>) are down sharply in early trading after DA Davidson downgrades to Underperform from Neutral.</li> <li>The firm warns of a cut in Nutrisystem's full-year guidance when Q3 earnings are released.</li> <li>Analyst Linda Bolton Weiser and team take their price target on Nutrisystem down to $28 from $40.</li> <li>NTRI&nbsp;<font color='red'>-7.28%</font>&nbsp;premarket to $34.40.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3397257\" data-linked=\"Nutrisystem -7% after DA Davidson cut\" data-tweet=\"$NTRI - Nutrisystem -7% after DA Davidson cut https://seekingalpha.com/news/3397257-nutrisystemminus-7-after-da-davidson-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3397257-nutrisystemminus-7-after-da-davidson-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397253\" data-ts=\"1539607582\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SCHW\" target=\"_blank\">SCHW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397253-charles-schwab-eps-and-revenue-in-line\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Charles Schwab EPS and revenue in-line</a></h4><ul><li>Charles Schwab (NYSE:<a href='https://seekingalpha.com/symbol/SCHW' title='The Charles Schwab Corporation'>SCHW</a>): Q3 GAAP EPS of $0.65 in-line.</li><li>Revenue of $2.58B (+18.9% Y/Y) in-line.</li><li>Shares <font color='green'>+1.02%</font> PM.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397253\" data-linked=\"Charles Schwab EPS and revenue in-line\" data-tweet=\"$SCHW - Charles Schwab EPS and revenue in-line https://seekingalpha.com/news/3397253-charles-schwab-eps-and-revenue-in-line?source=tweet\" data-url=\"https://seekingalpha.com/news/3397253-charles-schwab-eps-and-revenue-in-line\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397246\" data-ts=\"1539607036\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HRS\" target=\"_blank\">HRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397246-harris-discloses-preliminary-fq1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Harris discloses preliminary FQ1 results</a></h4><ul><li>Earnings per diluted share from continuing operations increased 31% to $1.78.</li><li>Reported fiscal 2019 first quarter revenue of $1.5B, up 9% compared with the prior year.</li><li>Revenue by segment: Communication Systems +16%; Electronic Systems, +9%; Space and Intelligence Systems +5%.</li><li>Updated its guidance for fiscal 2019: EPS from continuing operations of $7.80-$7.90 (from $7.65-$7.85), revenue in a range of $6.53B-6.65B (up 6-8% from fiscal 2018).</li><li><a href='https://seekingalpha.com/symbol/HRS' title='Harris Corporation'>HRS</a> <font color='green'>+3.3% </font>premarket</li><li>Previously: <a href=\"https://seekingalpha.com/news/3397150-harris-beats-0_06-beats-revenue\" target=\"_blank\">Harris beats by $0.06, beats on revenue</a> (Oct. 15 2018)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3397153-creation-l3-harris-technologies\" target=\"_blank\">The creation of L3 Harris Technologies</a> (Oct. 15 2018)</li></ul><div class=\"tiny-share-widget\" data-id=\"3397246\" data-linked=\"Harris discloses preliminary FQ1 results\" data-tweet=\"$HRS $LHX - Harris discloses preliminary FQ1 results https://seekingalpha.com/news/3397246-harris-discloses-preliminary-fq1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3397246-harris-discloses-preliminary-fq1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:37 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397244\" data-ts=\"1539607009\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TNDM\" target=\"_blank\">TNDM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397244-tandem-diabetes-care-up-6-premarket-on-canadian-ok-for-t-slim-x2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tandem Diabetes Care up 6% premarket on Canadian OK for t:slim X2</a></h4><ul><li>Tandem Diabetes Care (NASDAQ:<a href='https://seekingalpha.com/symbol/TNDM' title='Tandem Diabetes Care, Inc.'>TNDM</a>) is up&nbsp;<font color='green'>6%</font>&nbsp;premarket on modest volume following Health Canada's nod for its t:slim X2 Insulin Pump.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3397138-tandems-t-slim-x2-insulin-pump-okd-canada\" target=\"_blank\">Tandem's t:slim X2 insulin pump OK'd in Canada</a> (Oct. 13)</li></ul><div class=\"tiny-share-widget\" data-id=\"3397244\" data-linked=\"Tandem Diabetes Care up 6% premarket on Canadian OK for t:slim X2\" data-tweet=\"$TNDM - Tandem Diabetes Care up 6% premarket on Canadian OK for t:slim X2 https://seekingalpha.com/news/3397244-tandem-diabetes-care-up-6-premarket-on-canadian-ok-for-t-slim-x2?source=tweet\" data-url=\"https://seekingalpha.com/news/3397244-tandem-diabetes-care-up-6-premarket-on-canadian-ok-for-t-slim-x2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397243\" data-ts=\"1539606933\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HEAR\" target=\"_blank\">HEAR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397243-turtle-beach-makes-5m-note-payment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Turtle Beach makes $5M note payment</a></h4><ul><li>           Turtle Beach (NASDAQ:<a href='https://seekingalpha.com/symbol/HEAR' title='Turtle Beach Corporation'>HEAR</a>) <a href=\"https://seekingalpha.com/pr/17299799-turtle-beach-repays-another-5-million-subordinated-notes\" target=\"_blank\">repays</a> another $5M of its outstanding subordinated notes, bringing the balance to $10.4M. </li><li> The company has now paid $12.2M of the debt balance since March, representing about 54% of the total. </li><li> The repayment will reduce the annual interest expense by about $0.6M/year going forward.&nbsp; With the earlier payment, the reduction jumps to $1.2M/year. </li><li> Turtle Beach plans to repay the remaining balance by the end of March 2019 using operating cash flows. </li><li> HEAR shares are&nbsp;<font color='green'>up 4.3%</font>&nbsp;premarket to $21.50.&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3397243\" data-linked=\"Turtle Beach makes $5M note payment\" data-tweet=\"$HEAR - Turtle Beach makes $5M note payment https://seekingalpha.com/news/3397243-turtle-beach-makes-5m-note-payment?source=tweet\" data-url=\"https://seekingalpha.com/news/3397243-turtle-beach-makes-5m-note-payment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397237\" data-ts=\"1539606468\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LULU\" target=\"_blank\">LULU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397237-lululemon-breaks-higher-after-wedbush-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lululemon breaks higher after Wedbush upgrade</a></h4><ul> <li>Wedbush <a href=\"https://twitter.com/AnalystWire/status/1051781113922891776\" target=\"_blank\">upgrades</a> Lululemon (NASDAQ:<a href='https://seekingalpha.com/symbol/LULU' title='Lululemon Athletica Inc.'>LULU</a>) to an Outperform rating after having the retailer lined up at Neutral.</li> <li>The Wedbush analyst team assigns a price target of $176 on Lululemon. The all-time high for Lululemon is $164.79.</li> <li>Shares of Lululemon are <font color='green'>up 1.26%</font> in premarket trading to $145.52.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3397237\" data-linked=\"Lululemon breaks higher after Wedbush upgrade\" data-tweet=\"$LULU - Lululemon breaks higher after Wedbush upgrade https://seekingalpha.com/news/3397237-lululemon-breaks-higher-after-wedbush-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3397237-lululemon-breaks-higher-after-wedbush-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:27 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397224\" data-ts=\"1539605226\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KRYS\" target=\"_blank\">KRYS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397224-krystal-biotechs-gene-therapy-kb103-shows-encouraging-action-in-rdeb-study-shares-up-2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Krystal Biotech&#39;s gene therapy KB103 shows encouraging action in RDEB study; shares up 2% premarket</a></h4><ul><li><a href=\"https://seekingalpha.com/pr/17299918-krystal-biotech-announces-positive-interim-results-placebo-controlled-phase-1-2-clinical\" target=\"_blank\">Preliminary data</a> from a Phase 1/2 clinical trial evaluating Krystal Biotech's (NASDAQ:<a href='https://seekingalpha.com/symbol/KRYS' title='Krystal Biotech'>KRYS</a>) gene therapy KB103 in patients with dystrophic epidermolysis bullosa &#40;RDEB&#41; showed a treatment effect.</li><li>Two patients received topical KB103 followed by intradermal injections to intact skin. The data showed a meaningful clinical benefit with functional COL7 (collagen type 7) protein and anchoring fibril formation.</li><li>On the safety front, no safety signals were observed.</li><li><a href=\"https://rarediseases.info.nih.gov/diseases/2150/dystrophic-epidermolysis-bullosa\" target=\"_blank\">RDEB </a>is a rare inherited disorder characterized by fragile skin that blisters when subjected to even mild friction. It is caused by mutations in the COL7 gene.</li><li>The company and principal investigator will host a webcast at 8:45 am ET to discuss the results.</li><li>Shares are up&nbsp;<font color='green'>2%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397224\" data-linked=\"Krystal Biotech&#39;s gene therapy KB103 shows encouraging action in RDEB study; shares up 2% premarket\" data-tweet=\"$KRYS - Krystal Biotech&#39;s gene therapy KB103 shows encouraging action in RDEB study; shares up 2% premarket https://seekingalpha.com/news/3397224-krystal-biotechs-gene-therapy-kb103-shows-encouraging-action-in-rdeb-study-shares-up-2?source=tweet\" data-url=\"https://seekingalpha.com/news/3397224-krystal-biotechs-gene-therapy-kb103-shows-encouraging-action-in-rdeb-study-shares-up-2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:07 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397216\" data-ts=\"1539604730\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATVI\" target=\"_blank\">ATVI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397216-cod-black-ops-4-sets-new-day-one-records\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">COD: Black Ops 4 sets new day one records</a></h4><ul><li>        Activision Blizzard (NASDAQ:<a href='https://seekingalpha.com/symbol/ATVI' title='Activision Blizzard, Inc'>ATVI</a>) announces that Call of Duty: Black Ops 4 <a href=\"https://seekingalpha.com/pr/17299606-call-duty-black-ops-4-delivers-biggest-launch-day-one-digital-sales-activision-history\" target=\"_blank\">set a new</a> launch day record as the largest day one digital release in company history, breaking the previous record set by Call of Duty: WWII.</li><li>               The game, which was released on Friday, set a new PlayStation record for day one digital full game sales on PlayStation Store and became the best-selling Activision Xbox One game on day one.&nbsp;</li><li>               Analyst action: Barclays upgrades Activision Blizzard from Equal Weight to Overweight. (Source: StreetAccount.)&nbsp;</li><li>               ATVI shares are&nbsp;<font color='green'>up 1.4%</font>&nbsp;premarket to $78.98.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3397216\" data-linked=\"COD: Black Ops 4 sets new day one records\" data-tweet=\"$ATVI - COD: Black Ops 4 sets new day one records https://seekingalpha.com/news/3397216-cod-black-ops-4-sets-new-day-one-records?source=tweet\" data-url=\"https://seekingalpha.com/news/3397216-cod-black-ops-4-sets-new-day-one-records\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397211\" data-ts=\"1539603897\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/APPN\" target=\"_blank\">APPN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397211-appianplus-1_3-barclays-moves-to-equal-weight\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Appian +1.3% as Barclays moves to Equal Weight</a></h4><ul><li>        Barclays upgrades Appian (NASDAQ:<a href='https://seekingalpha.com/symbol/APPN' title='Appian Corp.'>APPN</a>) from Underweight to Equal Weight with a $29 price target, a&nbsp;<font color='green'>14% upside</font>&nbsp;to Friday&rsquo;s close. The firm cites valuation.</li><li>               Source: StreetAccount.&nbsp;</li><li>               Appian shares are&nbsp;<font color='green'>up 1.3%</font>&nbsp;premarket to $25.85. Shares are&nbsp;<font color='red'>down 10.4%</font>&nbsp;in the past week,&nbsp;<font color='red'>30.6%</font>&nbsp;in the month,&nbsp;<font color='red'>22.1%&nbsp;</font>in the quarter, and&nbsp;<font color='red'>19%</font>&nbsp;YTD. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3397211\" data-linked=\"Appian +1.3% as Barclays moves to Equal Weight\" data-tweet=\"$APPN - Appian +1.3% as Barclays moves to Equal Weight https://seekingalpha.com/news/3397211-appianplus-1_3-barclays-moves-to-equal-weight?source=tweet\" data-url=\"https://seekingalpha.com/news/3397211-appianplus-1_3-barclays-moves-to-equal-weight\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397208\" data-ts=\"1539603383\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AG\" target=\"_blank\">AG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397208-first-majestic-silver-produces-company-record-6_7m-silver-equiv-oz-in-q3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">First Majestic Silver produces company record 6.7M silver equiv. oz. in Q3</a></h4><ul>     <li>First Majestic Silver (NYSE:<a href='https://seekingalpha.com/symbol/AG' title='First Majestic Silver Corp.'>AG</a>)&nbsp;<font color='green'>+2.3%</font> pre-market after announcing <a href=\"https://seekingalpha.com/pr/17299861-first-majestic-produces-record-6_7-million-silver-equivalent-ounces-third-quarter\" target=\"_blank\">record quarterly production</a> of 6.7M silver equiv. oz. in Q3, consisting of 3.5M oz. of silver, 35.2K oz. of gold, 4.4 M lbs. of lead and 1.2M lbs. of zinc.</li>     <li>YTD silver production totaled 8.4M oz., or 15.8M silver equiv. oz., in-line with full-year production guidance of 12M-13.2M silver oz. or 20.5M-22.6M silver equiv. oz.</li>     <li>AG attributes the record quarter primarily to a full quarter of production from the San Dimas operation, along with respective 19% and 35% increases in  consolidated silver and gold grades, with five of its six mines recording higher production levels as a result of the grade improvements.</li>     <li>AG also says it is implementing a 20% cost reduction program across all areas due to prolonged silver price weakness.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3397208\" data-linked=\"First Majestic Silver produces company record 6.7M silver equiv. oz. in Q3\" data-tweet=\"$AG - First Majestic Silver produces company record 6.7M silver equiv. oz. in Q3 https://seekingalpha.com/news/3397208-first-majestic-silver-produces-company-record-6_7m-silver-equiv-oz-in-q3?source=tweet\" data-url=\"https://seekingalpha.com/news/3397208-first-majestic-silver-produces-company-record-6_7m-silver-equiv-oz-in-q3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397204\" data-ts=\"1539603048\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARGX\" target=\"_blank\">ARGX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397204-premarket-analyst-action-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - healthcare</a></h4><ul><li>Argenx (NASDAQ:<a href='https://seekingalpha.com/symbol/ARGX' title='Argenx SE'>ARGX</a>) initiated with Outperform rating and $110 (51% upside) price target at Evercore ISI.</li><li>Elanco Animal Health (NYSE:<a href='https://seekingalpha.com/symbol/ELAN' title='Elanco'>ELAN</a>) initiated with Equal Weight rating at Morgan Stanley. Initiated with Overweight rating and $38 (17% upside) price target at JPMorgan. Initiated with Buy rating and $37 price target at Citigroup. Initiated with Neutral rating and $30 price target at Goldman Sachs. Initiated with Outperform rating and $38 price target at Cowen and Company.</li><li>KalVista Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/KALV' title='KalVista Pharmaceticals, Inc.'>KALV</a>) initiated with Buy rating and $33 (76% upside) price target at Stifel.</li><li>Eli Lilly (NYSE:<a href='https://seekingalpha.com/symbol/LLY' title='Eli Lilly and Company'>LLY</a>) resumed with Neutral rating and $120 (9% upside) price target at Goldman.</li><li>Arbutus Biopharma (NASDAQ:<a href='https://seekingalpha.com/symbol/ABUS' title='Arbutus Biopharma Corp'>ABUS</a>) upgraded to Neutral with a $5 (16% upside) price target at Wedbush. Sharses up&nbsp;<font color='green'>2%</font>&nbsp;premarket.</li><li>AcelRx Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/ACRX' title='AcelRx Pharmaceuticals, Inc.'>ACRX</a>) upgraded to Buy with an $8 (101% upside) price target at Jefferies after the Ad Com nod for DSUVIA. Shares up&nbsp;<font color='green'>26%&nbsp;</font>premarket.</li><li>Zoetis (NYSE:<a href='https://seekingalpha.com/symbol/ZTS' title='Zoetis'>ZTS</a>) upgraded to Overweight with a $100 (12% upside) price target at JPMorgan.</li></ul><div class=\"tiny-share-widget\" data-id=\"3397204\" data-linked=\"Premarket analyst action - healthcare\" data-tweet=\"$ARGX $ARGX $ELAN - Premarket analyst action - healthcare https://seekingalpha.com/news/3397204-premarket-analyst-action-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3397204-premarket-analyst-action-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:30 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3397201\" data-ts=\"1539602560\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DELL\" target=\"_blank\">DELL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3397201-icahn-discloses-8-stake-in-dell-tracker-will-oppose-merger\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Icahn discloses 8% stake in Dell tracker, will oppose merger</a></h4><ul><li>        Carl Icahn <a href=\"https://carlicahn.com/carl-c-icahn-releases-open-letter-to-stockholders-of-dells-dvmt-tracking-stock/\" target=\"_blank\">writes an open letter</a> to Dell (DVMT) stockholders saying he plans to vote against the proposed merger. Icahn holds 8.3% of the Class V shares.</li><li>               Icahn says the Dell tracking stock currently sells for about $92/share but is worth &ldquo;on a pure mathematical basis&rdquo; about $144/share.&nbsp;</li><li>               Icahn blames the gap on the 2013 go-private transaction that left the market distrustful of Michael Dell and Silver Lake, the fact that the tracker &ldquo;has basically zero governance rights,&rdquo; and the gradual destruction of value due to &ldquo;scare tactics&rdquo; like floating the possibility of a Dell IPO.&nbsp;</li><li>               Dell announced in July that it would pay $21.7B in cash and stock to buy back shares that track VMware (NYSE:<a href='https://seekingalpha.com/symbol/VMW' title='VMware, Inc.'>VMW</a>). The company has a potential IPO as a Plan B if the merger fails to win shareholder support. &nbsp;&nbsp;</li><li>               DVMT shares are<font color='green'>&nbsp;</font><font color='green'>up 1.1%&nbsp;</font>premarket to $95.50.&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3394720-dell-confirms-ipo-talks-back-plan\" target=\"_blank\">Dell confirms IPO talks as back-up plan</a> (Oct. 3)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3395419-dell-will-list-nyse-tracking-stock-buyout-succeeds\" target=\"_blank\">Dell will list on NYSE if tracking stock buyout succeeds</a> (Oct. 5)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3395480-cnbcs-faber-dell-might-lack-votes-tracking-stock-buyout\" target=\"_blank\">CNBC's Faber: Dell might lack votes for tracking stock buyout</a> (Oct. 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3397201\" data-linked=\"Icahn discloses 8% stake in Dell tracker, will oppose merger\" data-tweet=\"$DELL $DELL $VMW - Icahn discloses 8% stake in Dell tracker, will oppose merger https://seekingalpha.com/news/3397201-icahn-discloses-8-stake-in-dell-tracker-will-oppose-merger?source=tweet\" data-url=\"https://seekingalpha.com/news/3397201-icahn-discloses-8-stake-in-dell-tracker-will-oppose-merger\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}